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ABSTRACT

Three trials were conducted to evaluate the

alterations of energy metabolism in ruminants fed a forage

or concentrate based diet supplemented with or without
lasalocid.

Trials 1 and 2 were designed in a 2 x 2 Latin

Square using 4 post-weaned wethers (avg BW = 57 kg) in each
trial.

Trial 1 used a high forage diet made up of 75%

alfalfa pellets and 25% rolled corn.

Trial 2 used a high

concentrate diet of 75% rolled corn and 25% alfalfa

pellets.

Wethers were equipped with indwelling catheters

in the portal, hepatic, and mesenteric veins, caudal aorta
and caudal vena cava.

A series of 6, 12 ml samples were

taken from femoral artery, hepatic, portal and femoral
veins and whole blood was analyzed for PAH, acetoacetate

(ACAC), beta-hydroxybutyrate (BOHB), glucose and lactate.
Plasma was analyzed for non-esterified fatty acids (NEFA)
and VFA.

In Trial 1 splanchnic blood flow rates were

decreased (P < .01) by lasalocid, while peripheral blood
flow was increased (P < .01).

Lasalocid supplementation in

Trial 1 increased (P < .01) hepatic production of glucose

and lactate by portal drained viscera (PDV).

Production of

BOHB by hepatic tissue in Trial 1 was lower (P < .05) and

animals supplemented with lasalocid had increased (P < .01)
PDV release of propionate.

In Trial 2, portal blood flow

was reduced (P < .01) in animals supplemenced with

lasalocid.

Glucose release by the liver was similar

between treatments in Trial 2 despite increased (P < .05)
PDV release in wethers fed Lasalocid.

Unlike Trial 1,

wethers fed a high concentrate diet had decreased (P < .01)
PDV release of BOHB.

Trial 3 was conducted using a rumen

epithelial cell incubation technique.

Five sheep were

used, fed a high forage diet with or without supplemental
lasalocid.

Rumen epithelium was collected after slaughter

and incubated in media containing acetate, propionate and

butyrate.

Acetoacetate, BOHB, lactate and pyruvate

increased through 120 min in both treatments indicating
continued cellular metabolism.

No differences between

treatments in any metabolite concentrations were detected.
In these trials no evidence was observed to substantiate

possible effects of ionophores on host cell metabolism.
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CHAPTER

I

INTRODUCTION

The use of non-nutritive feed additives to increase

intake or improve feed efficiency has become extremely
important in recent years.

It has become necessary to

develop additives that will increase the efficiency with
which cattle utilize feed to maintain competitiveness with
the swine and poultry industries.

The most popular feed

additives used to improve feed efficiency are a class of

compounds known as polyether ionophore antibiotics,

lonophores alter the movement of specific ions across cell
membranes and are classified by their affinity for a

specific ion.

Lasalocid is classified as a compound with a

greater affinity for K"*" than Na"^ (Pressman, 1976).
The most frequently reported effect of lasalocid and
other ionophores in vivo is a shift in the ratio of
volatile fatty acids in the rumen.

lonophores increase the

proportion of propionate with simultaneous decreases in the
proportions of acetate and butyrate (Richardson et al.,
1976; Thornton et al., 1976; Hartley et al., 1979).

Romatowski (1979), as reported by Bergen and Bates (1984)
stated that lasalocid action is a two part mechanism with a

resulting efflux in K"*" and influx of Na"^ with cation
transport occurring in both directions across membranes.
The net flux of nutrients through the portal drained
viscera (PDV), liver and hindquarters can be measured by

using chronic multicatheterization procedures.

This

technique has been used previously to describe changes in
nutrients which appear in portal blood following the
inclusion of ionophores in feed, (Harmon and Avery, 1987;
Harmon et al., 1988; Harmon et al., 1989) although, there

is only one published report on the changes in hepatic flux
of nutrients and this report evaluated monensin (Harmon et
al., 1993).

Further, effects of ionophores on rumen

epithelium in vitro have not been evaluated.

Therefore,

the objective of this research was to evaluate the effects
of lasalocid on diets of differing forage to concentrate

ratios and its effects on rumen epithelial cells, as well
as describing changes in PDV, hepatic and hindquarter
tissue metabolism in vivo.
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CHAPTER II
LITERATURE REVIEW
LASALOCID: MODE OF ACTION

Lasalocid is termed a carboxylic ionophore because of
the existence of an ionizable terminal carboxyl.

Mode of

action of lasalocid is a function of its molecular

configuration and polarity of the environment in which it
is contained.

It was reported that the essence of

lasalocid mode of action is its ability to
stoichiometrically bind with metal cations and facilitate
their transport across biological membranes (Ovchinikov,
1979).

The action of lasalocid is a function of its two

structural configurations.

Figure 1 depicts the acyclic form of lasalocid which
is the dominant form in media with a high polarity, e.g.

lipid biological membranes.

This form precedes so called

ion capture and is best termed as quasi-linear, with an ion
binding cavity.

The conversion of acyclic to cyclic

conformation is accomplished by bond angle changes

occurring at "hinge" sites (Figure 2).
identified in Figure 2 by the arrows.

The hinge sites are
It is within this

cyclic form that the cation is bound or captured.
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Cyclic structure of lasalocid.
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The ultimate ionophore-cation complex, represented by

the equation M"*" + I" =

(where M represents the metal

ion and I the ionophore) requires the ability of the
ionophore to remove the cation from the bulk fluid solvent
(Bergen and Bates, 1984).

This complex stability can be

expressed thermodynamically (Gibbs free energy) by the sum
of various free energy components (Painter and Pressman,

1985).

The energy required for stability of the complex is

the sum of the net energies required for transfer of the
cation from solvent to ionophore, to desolvate the backbone
allowing for movement of hinges, and to complete conversion
of molecules to the complexed form, and minus the energy
interaction between the ionophore and its captured cation
(Eisenman et al., 1968; Pressman, 1976; Haynes and
Pressman, 1974a; Haynes and Pressman, 1974b and Pressman,
1976).

Orientation of the ionophore at physiological pH is in
the exterior of the lipid membrane bound by negatively
charged carboxylate.

This carboxylate charge places the

ionophore in an anionic form.

An encounter of this form

with a cation results in a release of H2O contained in
ligand binding sites.

The ionophore then wraps around the

cation in almost a phagocytic engulfing of the cation.
This zwitterion form becomes electrically neutral and able

to traverse the membrane to the cytoplasmic side.

Passive

diffusion of the zwitterionic form is due to the outward

orientation of the lipophillic backbone.

Upon encountering

the polar environment of the internal membrane interface,
stabilization forces now make it possible for the release
of the cation to the internal environment.

The ionophore

is subsequently bound to the polar membrane and must be
neutralized to complete its transmembrane cycle.
The outward movement of the ionophore can be

accomplished in one of three ways.

First the ionophore can

bind to an ion similar to that which was previously

transported.

Second, the ionophore is also available for

the binding of another cation and its subsequent outward
translocation, or third, it may extract a hydrogen atom to

counter the negative charge (Painter and Pressman, 1985).
The transport of divalent cations is similar to the

monovalent transport described above.

However, a major

difference exists in that the ionophore initially forms a

1:1 complex, similar to monovalent transport, followed by
another form which provides a stable complex of two ions to
one ionophore molecule.

This 2:1 complex describes the

form used by both lasalocid and A23187 in Ca^"*" and Mg^"^
transport (Kolber and Haynes, 1981; Otake and Mitani,
1979).

As a monovalent and divalent cation transporter,

lasalocid possesses greater affinity for K"*" over Na"*" and

Ca^"*" over Mg^"*" (Haynes et al., 1980).

These researchers

documented an electrically neutral transport of Ca^"*" into
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the bacterial cell and two K"*" to the cellular exterior.

This type of transport allows for a maintenance of
electrical integrity of the cell.

They also reported that

a possible rate limiting step to lasalocid action (under

optimum conditions) could lie in the availability of K"^ for
transport to the extracellular environment.

The relative

affinity for monovalent vs. divalent cations is also of
consideration in a physiological situation.

Lasalocid has

a similar K^, for binding, for Na"*" and Ca^"*" and a lower
for the monovalent K"^ ions.

Research describing the

affinity of lasalocid for specific cations was conducted in
vitro.

Transport of cations in vivo may be affected by the

relative affinity of the ionophore for a cation as well as
the concentration gradients present across biological
membranes (Bergen and Bates, 1984).

lonophores may be absorbed by gut tissue (Davison,
1984; Painter and Pressman, 1985).

If it is assumed that

these cation transport affects can occur in any mammalian

lipid bilayer membrane

and since gut tissue and hepatic

tissue are in series in terms of blood circulation, hepatic

metabolism may be dramatically altered by the feeding of
ionophores.

INTRARUMINAL ALTERATIONS

Gram-Negative Selectivity
Net effects of feeding ionophores have been described
by numerous researchers (Richardson et al., 1976; Thornton
et al., 1976; Chalupa, 1980).

These studies have reported

a change in the ratios of VFA produced in the rumen, i.e.,
increased propionate:acetate ratio.

However, effects of

change in metabolic products and shifts in microbial

population on total body metabolism remains a subject of
debate.

There is also no direct explanation of the

mechanism by which most gram negative bacteria are
unaffected and the majority of the gram positives are
affected by ionophores.

Chen and Wolin (1979) reported bacteria which produce

succinate and propionate were selected for by the feeding
of monensin and lasalocid.

Fumarate reductase is prevalent

in gram negative bacteria such as Ruminococcus
flavefaciens. This is important because the succinate

produced by the gram negative bacteria is metabolized to
propionate by other bacteria.

Therefore, a subsequent

increase in rumen proportion of propionate relative to that
of acetate and butyrate occurs.

It was further

hypothesized by Chen and Wolin (1979) that the addition, or
possible proliferation, of this species along with
Ruminococcus albus and Bacteroides fibrisolvens (both of
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which are also resistant to ionophores), may decrease the
major end products acetate and butyrate.

This decrease

would result in a shift in the propionate:acetate ratio.
Resistance of some bacteria to the antibiotic action

of ionophores may be a function of cellular morphology

(Russell and Strobel, 1989).

Most gram-negative bacteria

are resistant to the effects of ionophores.

The resistance

of gram-negative bacteria can be traced to the presence of
a double cellular membrane.

Nikaido and Nakae (1979)

reported that outer membranes of gram-negative bacteria are

impermeable to large molecules.

The basis for this

impermeability is the existence of hydrophillic channels.
Ionophores are large hydrophobic molecules and therefore

are selectively retarded from inclusion in gram-negative
bacteria.

Gram-positive bacteria lack this outer membrane and

thus are sensitive to the action of ionophores (Russell and
Strobel, 1989).

However, exceptions exist.

Bacteria

staining gram-negative that possess the characteristic cell
wall structure of gram-positive organisms are sensitive to

ionophores (Hungate, 1966; Cheng and Costerton, 1977).
This explanation of the action of ionophores seems to be

well accepted throughout the research community.

However,

a list of observations that must be considered is described

below (adapted from Russell and Strobel 1989):
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1)

There are some gram-negative bacteria that lack

resistance to high concentrations of
ionophores.
2)

Researchers have documented increased ion flux

in bacteria staining gram-negative.

3)

An adaptation of sensitive gram-negative
species to ionophores has been reported.

4)

There is some documentation of gram-positive

bacteria developing a resistance to ionophores.

5)

Some ciliated protozoa and fungi are resistant
to ionophores.

Based on the observations of other researchers, Russell and

Strobel (1989) concluded that the presence of an outer

membrane is not the only reason for an organism to exhibit
resistance to an ionophore.

There also have been reports

of cross-resistance of some bacterial species.

Chen and

Wolin (1979) reported Bacteroides strains may be resistant
to monensin but not lasalocid, and other bacteria possess
opposite resistance.

Changes in Ruminal pH and Methane

Ruminal pH is affected by diet.

A high forage diet

will result in a more neutral pH, while a high concentrate

diet will result in a decrease in pH which may eventually
lead to acidosis.

Dennis et al. (1981) first reported

lasalocid decreased lactic acid concentration in vitro.
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These researchers, concluded that lactic acid producing
bacteria were inhibited while the bacteria which utilize

lactate were not affected.

Nagaraja et al. (1982) and

Nagaraja and Taylor (1987) investigated the effectiveness
of both lasalocid and monensin in lowering rumen pH when
animals received extremely large quantities of grain.

Both

compounds were effective in raising rumen pH by reducing
lactate accumulation, with lasalocid being the more
effective.

Methane production and subsequent loss from the system

can represent a major energy loss during fermentation.

The

reduction of methane production in the rumen could allow
for an increase in other metabolites, such as propionate,
that serve as "hydrogen sinks."

Lasalocid has been

reported to decrease methane production by as much as 30%,

allowing for this otherwise lost energy to be recaptured
(Schelling, 1984).

The mechanism by which ionophores

reduce methane production is not due simply to a decrease
in methanogenic bacteria.

Russell and Strobel (1989)

reported that methanogenic bacteria are not susceptible to
the effects of ionophores.

Further investigation revealed

that the decrease in methane production was due to the
abundance of succinate and propionate producing bacteria
and a decrease in those which produce formate and hydrogen
ions (Chen and Wolin, 1979).

They concluded that the

decreased methane production must be due to a decrease in
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hydrogen ion concentration, which is the rate limiting
substrate in the formation of methane (Russell and Strobel,

1989).

Because of the decrease in methane it may be

incorrectly assumed that ATP production could be negatively
affected due to the concomitant increase in propionate
concentrations.

The ability to produce ATP at the step of

fumarate reductase was shown by Kroger and Winkler (1981).
A reduction in acetate by the addition of monensin in
semicontinuous cultures had no effect on ATP production
(Short et al., 1978, as reported by Russell and Strobel,
1989)

Further, it was stated by Russell and Strobel

(1989), "that propionate, due to its higher degree of

enthalpy than acetate, can be used by the animal for
increased feed energy."

When one considers all the changes that occur in the
rumen environment there are still some unanswered

questions.

Raun et al. (1976) reported that the shift to

greater propionate production could not account for the
greater gains seen in feedlot experiments conducted with

monensin and lasalocid.

Bergen and Bates (1984) maintain

that changes observed in rumen and lower gut cannot account

for the magnitude of observed improvements in feed
efficiency.
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EFFECTS ON DIGESTIBILITY SITE AND EXTENT

Diet is a major factor in the action of ionophores.
Forage to concentrate ratio can dramatically alter the net

effect of feeding ionophores.

Animals receiving primarily

a forage diet with added ionophore increase intake while

maintaining similar average daily gains.

Ruminants

receiving high concentrate diets have increased average
daily gains with similar intakes.

Digestibility of High Forage Diets
Addition of monensin to mixed ruminal bacteria

decreased cellulose digestion (Russell and Strobel, 1989) .
Others have reported no decrease in total fiber
digestibility with the in vivo feeding of ionophores
(Dinius, 1976) because a decrease in rate of passage would
allow for a more extensive ruminal fermentation (Russell

and Strobel, 1989).

A second reason for the more complete

use of feed may be maintenance of pH at a relatively
neutral point.

Stewart (1977) found a marked sensitivity

of cellulolytic bacteria to an acidic pH.

Ionophores can

reduce lactic acid production, which in turn will allow pH
to remain very near neutral.

There is a species dependent response to digestibility
when animals are supplemented with ionophores.

Spears

(1990) concluded from an extensive review of the

literature, that both monensin and lasalocid increased
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digestibility in cattle but had no effect on apparent
digestibility in sheep.

However, this could be an artifact

of the different diets utilized in each of the studies

(Spears, 1990).

The differences in diets seem to be a

function of the source of fiber.

In all cases, ionophores

decreased or had no effect on fiber digestibility.

For

example, monensin decreased fiber digestibility in lambs
fed a diet of 50% cottonseed hulls (Vijchulata et al.,
1980), and sheep fed corn silage-based diets.

The lowering

of digestibilities seems to be confined to the forage
portion of the diet with the concentrate portion
unaffected.

Digestibility of High Concentrate Diets
There is no effect of ionophore feeding on extent of
starch digestion, as reviewed by Spears (1990).

The

increased feed efficiency resulting from the addition of
ionophores may be a function of a shift in site of
digestion from rumen to small intestine.

Lasalocid

depressed ruminal starch fermentation while simultaneously
increasing digestion in the small intestine (Funk et al.
1986) confirming results reported earlier by Muntifering et
al. (1980).

According to Spears (1990) this shift in site

of digestion should result in a more efficient utilization
of starch, by sparing glucose fermentation to VFA.
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CHANGES IN PLASMA METABOLITES

Changes occurring in concentrations of blood
metabolites in animals receiving supplemental ionophores do
not always reflect ruminal production.

Propionate and

glucose have received the most attention because they have
exhibited the most consistent changes in concentration and
fluxes with the feeding of ionophores and have the most
profound effect on feed efficiency.
Wahle and Livesey (1985) reported increased propionate
concentrations in jugular blood with supplementation of
monensin.

Since glucose concentrations tended to increase

as well, the increased concentrations of propionate may

have been due to an increase in portal drained viscera
(PDV) production and not a decrease in hepatic propionate
utilization.

More definitive, quantitative assessment of changes in
peripheral metabolism were reported in studies conducted
using chronic multicatheterization.

In each study

propionate release by PDV was similar for controls and

animals supplemented with ionophores.

Therefore, the

increased propionate produced in the rumen by

supplementation with ionophores may be used by rumen

epithelium as an energy substrate.

Use of propionate may

be associated with reported decreases in glucose uptake by
PDV (Harmon and Avery (1987); Harmon et al., 1989 and

Harmon et al. 1993).

There are two plausible explanations
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for the decrease in PDV glucose uptake.

First, propionate

may have a sparing effect on glucose (Harmon and Avery,
1987; Harmon et al., 1989 and Harmon et al., 1993).

Harmon

and coworkers have proposed that the PDV may utilize

propionate as its primary energy source in lieu of
extracting glucose from portal circulation as the primary

energy source.

A second explanation is a possible increase

in starch digestion occurring in the lower digestive tract

(Muntifering et al., 1980).

This would essentially

increase unidirectional uptake of glucose without changing
unidirectional utilization; therefore, decreasing net
utilization.

Conversely, Harmon et al. (1988) reported

increased ruminal proportions (or concentrations) of

propionate and increased release of propionate by PDV into

portal circulation in steers supplemented with monensin or
salinomycin.

However, this may have been partially due to

an increase in blood flow rates through PDV.

With

increasing concentrations of propionate occurring in both
the rumen and portal vein, the implication is that bovine

rumen epithelial metabolism of propionate is unchanged
(Harmon et al., 1988).

Harmon et al. (1989) reported a decrease in molar

proportion of rumen acetate in vitro.

A decrease in rumen

acetate coupled with similar or increased PDV acetate flux
rates would imply that PDV utilization of acetate had been

in some way altered (Harmon et al., 1989).

A similar study
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by Harmon et al. (1993) using monensin as the supplemental
ionophore failed to show a decrease in ruminal acetate.
Lactare concentrations have varied between reports.
Arterial lactate was shown to increase (Harmon et al.,

1988), indicating a catabolism of propionate and/or
glucose, most probably by rumen epithelial tissue (Harmon
et al., 1989).

However, Harmon et al. (1993) reported no

change in ?DV lactate production in steers supplemented
with monensin.

There are no reports investigating metabolic changes
of extraruminal tissue beds in vivo.

Changes in metabolite

concentrations appearing in portal blood and hepatic
fluxes, together with the possibility of substantial

absorption of the intact ionophore, could have profound
effects on extraruminal metabolism.

POTENTIAL EXTRA-RUMINAL EFFECTS

Reports addressing possible extraruminal effects of
ionophores are few and, in many cases, contradictory and/or
incomplete.

There has been only one attempt to investigate

extraruminal response of animals fed monensin using
multicatheterization (Harmon et al., 1993).

However, these

responses have not been investigated with lasalocid.

The

tissue of greatest interest is the liver because of its
importance in the supply of glucose and ketone bodies for
ruminant metabolism.
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Changes in hepatic and peripheral glucose metabolism
with supplemental ionophore may be attributed partially to
increased propionate release by the PDV and partially due

to possible alterations of tissues by the ionophore itself.
As stated previously, a change in lactate concentrations
may be an indication of altered PDV, liver or peripheral
metabolism (Harmon et al., 1989).

A tendency for arterial

lactate concentrations to increase (Harmon et al., 1988;

1989) may be indicative of a change in hepatic function.
An alternative hypothesis to changes that are

dependent on increased propionate release from the PDV is a
direct effect of the ionophore on peripheral tissues.

Davison (1984) and Donoho (1984) used [^^C] labeled
monensin and found that 36 - 50% of ionophore fed is

absorbed directly into portal blood.

However, it is

possible that the label may have been tagged to a break
down product.

Circulating ionophore may have an affect on

extraruminal metabolic activity.

Armstrong and Spears

(1988) administered monensin (40 mg in 1 ml vehicle
absolute ethanol), or lasalocid (40 mg in 1 ml vehicle
absolute ethanol), or placebo (1 ml vehicle absolute
ethanol) via the vena cava for three consecutive days.
Administration of monensin increased (P < .05) circulating

free fatty acids and glucose over controls and lasalocid
treated animals.

Insulin was increased (P < .05) at 2 h

post injection in animals treated with monensin.

No
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changes were observed in animals treated with lasalocid.

Armstrong and Spears (1988) attribute this lack of action
to differing cation binding properties of the two

ionophores.

However, while monensin readily went into

solution, lasalocid did not, and was administered in

suspension.

They state that this type of administration

could have possibly inhibited ionophore action.

Hochman

and Perlman (1976) reported an increased release of
catecholamine from chromaffin cells following treatment
with a divalent ionophore in vitro.

This indicates

lasalocid might elicit a similar response as monensin

through its ability to bind with Ca^"*" and subsequently
increase intracellular Ca^"*" availability.

An increase in

intracellular Ca^"*" could also have a profound effect on
secretion of insulin, by decreasing intracellular pH and

increasing intracellular Ca^"*" (Kanatsuka et al., 1987).
Armstrong and Spears (1988) reported a decrease in

circulating concentrations of K"'", P"*" and Mg^"*" with
ionophore supplementation.

Changes in mineral

concentrations along with increases in concentrations of
free fatty acids and glucose were consistent with results
obtained by Rayssiguier (1977) and Bolton and Weekes (1986)
with infusions of epinephrine. Therefore, feeding
ionophores may result in an increase of the catecholamines,
most notably epinephrine as reported by Hochman and Perlman
(1976).
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Benz et al. (1989) compared monensin and lasalocid in
steers and no differences were detected for serum mineral

metabolites or mineral content of liver tissue.

However,

hepatic dihydroxyacetone phosphate, glyceraldehyde-3
phosphate and glycerol 3-phosphate levels were higher in
animals treated with lasalocid than in monensin treated

animals.

In addition lactate:pyruvate ratio decreased

while fructose 2,6-bisphosphate tended to decrease.

Hers

and Van Schaftingen (1982) found that fructose 2,6-

bisphosphate is a powerful stimulant of 1,6bisphosphofructolcinase as well as a inhibitor of fructose
1,6-bisphosphatase.

The elevation of phosphofructokinase

coupled with the decline in levels of fructose 1,6bisphosphatase would tend to favor the glycolytic pathway.
Thus an ionophore mediated decrease in fructose 2,6-

bisphosphate would drive the pathway in the direction of
increased gluconeogenesis.

From these data it appears that

the feeding monensin and lasalocid may increase the
potential of the liver for gluconeogenesis.

This change in

metabolic state of hepatic tissue has been shown by Wahle

and Livesey (1985) through ionophore supplementation of
sheep fed either a high forage or high concentrate diet

with or without ionophore.

Sheep were found to have the

ability to alter hepatic function to accommodate an
ionophore mediated increase in propionate reaching that

tissue.

Despite an increase in the ability of liver to
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metabolize propionate, concentrations increased in

peripheral blood.

Wahle and Livesey (1985) found that

peripheral tissues may have an increased capacity for
propionate metabolism and increased activity of propionylCoA carboxylase in adipose tissue.
Although much literature exists to substantiate an

increased gluconeogenic potential of hepatic tissue on
diets supplemented with ionophores, Harmon et al. (1993)
was unable to show an increase in liver production of
glucose with monensin feeding.
It is still unknown whether this gluconeogenic
potential can be attributed solely to increased propionate
presented to the liver, or is a direct effect of the

ionophore itself.

Limited research exists on the effects

of ionophores on in vivo hepatic metabolism.

RUMEN EPITHELIAL VFA METABOLISM

The principle VFA found in the rumen are acetate,
propionate and butyrate.

Two of the earliest reports of

the concentrations of three major VFA was Elsden (1945) and
El Shazly (1952).

It also was determined that rumen VFA

absorption occurs at a rate which increases with chain
length (Danielli et al., 1945).

Much of the ME utilized by

the ruminant is obtained from the metabolism of VFA.

Of the three key VFA, acetate occurs in the highest
proportions.

Although Pethick et al. (1983) reported that
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acetate is a priciary energy source for peripheral tissue,
it may also act as an important alimentary energy source.
Bergman and Wolff (1971) found 30% of absorbed acetate was
used by rumen epithelium during absorption in sheep fed

alfalfa hay.

Wolfe and Jahoor (1990) reported that this

estimation was conservative.

Harmon et al. (1991) found

comparable rates of oxidation to CO2 of acetate and
butyrate.

However, Pennington (1952) showed that ketone

production from butyrate was much greater than acetate in
rumen papillae incubates.

Propionate is one of the major precursors of glucose
in the ruminant animal.

Because little or no glucose is

released by visceral tissue, the ruminant must rely on

gluconeogenesis for its circulating concentrations of
glucose (van der Walt et al., 1983).

In a fed state,

propionate may account for 20 - 60% of the animals glucose
supply (Steel and Leng, 1973).

The ability of rumen

epithelium to metabolize propionate was initially discussed
by Pennington and Sutherland (1956) and studied in more
recent in vivo and in vitro reports (Cook, 1970; Weekes,
1974 and Emmanuel, 1981).

Bergman and Wolff (1971)

reported that up to 50% of propionate produced within the
rumen may be metabolized by rumen epithelium.

The

metabolism of propionate occurs in the following pathway
(Emmanuel, 1981) :

Propionate --> propionyl-CoA --> methyl-malonyl-CoA
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--> Succinyl-CoA --> succinate --> fumarate

malate --> pyruvate --> L-lactate
A variety of explanations have been given for the
physiological significance of rumen epithelial propionate
metabolism to lactate (Emmanuel, 1981).

First, lactate

formation could conserve three carbon units for hepatic
gluconeogenesis (Young et al., 1969).

Second, Weekes

(1974) reported that propionate metabolism provides
extramitochondrial NADH required for synthetic processes
within the cell.

The final step in propionate metabolism, reduction of
pyruvate to lactate, requires an NADH to proceed.

Although

unfavorable to the overall energetics of the cell, Emmanuel
(1981) stated it may serve as a control of

extramitochondrial redox state and ketogenesis supporting
earlier work by Weekes (1974).

Weekes (1974) found

propionate metabolism to be controlled by availability of
substrate and rate of propionyl-CoA formation (Weekes,
1974).

Further, it was reported by Weekes (1974) that

propionate metabolism by rumen epithelial tissue is

relatively insensitive to the concentrations of other VFA
present in the rumen.

Butyrate is extensively metabolized by rumen
epithelium (Harmon et al. 1991).

The primary end product

of butyrate metabolism is the ketone body S-hydroxybutyrate
(BOHB) and to a lesser extent acetoacetate (Harmon et al.

25

1991).

Pennington and Pfander (1956) and Weigand et al.

(1972) reported that 75 - 82% of absorbed butyrate is
converted to BOHB.

Total Icetone body production can

account for as much as 90% of the absorbed butyrate

(Weigand et al., 1972) .

Ketone bodies are primarily

associated with the pathologic state of Icetosis.

However,

they have been more recently identified as an important
energy source.

Heitmann et al. (1987) stated that release

of ketone bodies by portal drained viscera can account for
approximately 7% of the energy requirement for sheep.

Butyrate metabolism is also affected by intake.
Harmon et al. (1991) found increased ketone production from

butyrate with increasing intake.

Harmon et al. (1991)

stated that this data indicate butyrate assisted rumen

epithelial development.

Increasing intake would

subsequently increase the supply of butyrate, possibly
elevating metabolic activity of the epithelial tissue
(Harmon et al., 1991).

Early in vitro studies showed negligible effects of
propionate on the metabolism of butyrate to ketones

(Pennington and Pfander, 1955 and Bush et al., 1970).
However, acetate addition to rumen epithelium did lower

ketone production from butyrate (Pennington and Pfander,
1956; Bush et al., 1970).

Data collected in vivo indicate that increasing

propionate concentrations in the rumen by ionophore
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supplementation did not affect rumen epithelial ketone body
production (Harmon et al., 1988; 1993).

Further, these

reports were unable to detect a shift in the ratio of BOHB

to acetoacetate with elevated levels of propionate.

vitro data contradicts these findings.

In

Bush et al. (1970)

and Baldwin and Jesse (1993) both report a shift in the
ratio of ketone bodies to greater concentrations of BOHB

with reduction of acetoacetate.

Conversion of butyrate to

BOHB requires as a final step the reduction of acetoacetate

to BOHB, using an NADH as the H"*" donor.

It is at this step

that propionate metabolism may have an affect on ketone
production and ratio of BOHB to acetoacetate.

In

metabolism of propionate the mitochondrial step of malate
to oxaloacetate generates an NADH.

This NADH is then

available for use in the reduction of acetoacetate to BOHB.

In vivo data has established a greater concentration
of BOHB than acetoacetate released by portal drained
viscera (Heitmann and Fernandez, 1986; Heitmann et al.,
1987; Lembo et al., 1993).

It has been found that

acetoacetate concentrations can exceed BOHB by as much as
3-4 to 1 in vitro (Weigand et al., 1972; Baldwin and Jesse,
1993).

Butyrate may also be dependent on propionate to

counteract possible negative effects of acetate on butyrate
metabolism.

The effect of acetate has not been well

documented but may be a direct competition of the formation
of acetyl-CoA and butyryl-CoA (Baldwin and Jesse, 1993).
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CHAPTER III

ALTERATIONS OF ENERGY METABOLISM IN
RUMINANTS FED A FORAGE BASED DIET
WITH OR WITHOUT LASALOCID
INTRODUCTION

Lasalocid, a polyether ionophore antibiotic, is an

important feed additive in the beef cattle industry.
Addition of ionophores to high forage diets results in an
increased feed intake and fiber digestibility (Spears,
1990).

However, recent reports have evaluated possible

direct effects of ionophores on host cell metabolism, more
specifically, portal drained viscera (PDV; Harmon et al.,

1988) and subsequent energy metabolism by hepatic tissue
(Harmon et al., 1993).

Ruminal proportions of propionate increase with
ionophore supplementation, but did not change release of
propionate into portal blood (Harmon et al. 1988; 1993).

Glucose uptake by PDV was decreased with ionophore feeding
suggesting that increased PDV utilization of propionate is
occurring and sparing glucose (Harmon et al., 1988; 1993) .
Benz et al. (1989) found an increase in hepatic
gluconeogenic potential when ruminants were supplemented

with ionophores, suggesting a possible effect on hepatic
tissue.

The objective of this study was to evaluate PDV,

hepatic, and peripheral tissue energy metabolism in
ruminants fed a high forage diet with or without
supplemental lasalocid.

28
MATERIALS AND METHODS

Animals

Four weaned wethers (average BW =57+4 kg) were used
in a balanced 2x2 Latin Square to evaluate effects of
lasalocid addition to a high forage diet on splanchnic and
peripheral energy metabolism.

Animals were allotted

randomly to treatment and housed in individual 1.8 x 3.0 m

pens contained in a room with natural lighting.

Ambient

temperature was maintained between 17 and 25°C.

Wethers

were allowed free access to fresh water.

Surgical Procedure

Wethers were transported to the experimental facility

at least 5 d prior to surgery for acclimation to the

facility.

Feed was removed 24 h, and water removed 12 h

prior to surgery.

Surgical procedures were conducted as

described by Katz and Bergman (1969), with modifications
made by Zanzalari et al. (1989).

Chronic indwelling

catheters were placed in the portal, hepatic, mesenteric
veins, caudal aorta and caudal vena cava.

A broad spectrum

antibiotic was given immediately following surgery and once
daily for 3 d.

Animals were allowed 14 d for recovery

during which body temperature and wound healing were
monitored daily.
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Diets

Alfalfa pellets (17% CP) and steam rolled corn (10.1%
CP) were mixed on a dry matter basis (determined by oven
drying at 60° in a forced air oven) 75% and 25%
respectively.
h).

Animals were fed 1.5 kg in one feeding (0800

Orts were negligable.

Nutrient consumption exceeded

the NRC (NRC, 1985) requirements CP for post weaning
wethers.

Wethers were allowed free access to salt and trace

mineral blocks throughout the experiment.

Two forage based

diets were utilized; with or without supplemental lasalocid.
Lasalocid (Hoffman-LaRoche, Princeton, NJ) was supplemented

as a top dress over both corn and alfalfa pellets at 44
mg/kg by daily addition to feed (Table 1).
Blood Sampling

Treatment periods were 12 d, with blood collection on d
12.

Blood sampling was preceded by a primed, continuous

infusion of para-aminohippurate (PAH, 1.5% @ .764 ml/min)
into a mesenteric vein.

Following 1 h equilibration period,

12 ml blood samples were collected simultaneously from the

portal and hepatic veins, caudal aorta and caudal vena cava.

Blood was sampled at 30 min intervals (0900 to 1130 h).
Following the final collection (1130 h), the infusion line
was removed from the mesenteric vein and placed on the
caudal aorta and PAH was infused as previously described.
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Table 1.

Analysis of forage based diet fed with or without

lasalocid.

Item

Control

Lasalocid

Requirement^

DMI (kg/d)

1.5

1.5

ME (Mcal/d)

3.6

3.6

3.6

251.0

251.0

234.0

14.1

14.1

8.6

4.4

4.4

4.3

CP (g/d)

Ca (mg/d)
P (mg/d)
Lasalocid

(mg/d)

0

66

--

TM salt^
(free choice)

^RC. 1985. Nutrient requirements of sheep. 6th revised ed.

"Composition of TM salt block:

NaCl, not more than 99%, not

less than 95%; Zn, not less than .35%; Fe, not less than
.34%; Mn, not less than .20%; Cu, not less than .033%; I,
not less than .007%; Co, not less than .005%.
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Following 30 min equilibration, 3 ml blood samples were
drawn from the caudal vena cava and jugular vein (via
jugular puncture).

A total of three collections were done

at 15 min intervals.

These samples were used in the

determination of hindquarter blood flow.
were used to estimate arterial blood.

Jugular samples

This is applicable

because PAH is not metabolized by cranial tissue.

Samples

were collected in syringes pretreated with Na-EDTA (6% w/v)
as an anticoagulant.

Catheter patency was maintained

between samples and during treatment periods using Na-EDTA
(6% w/v).

Laboratory Analysis

Whole blood samples were analyzed within 24 h for PAH
(Kaufman and Bergman, 1971), S-hydroxybutyrate (BOHB) and
acetoacetate (ACAC) (Williamson and Mellanby, 1965), and
glucose (Sigma glucostat 510 kit, Sigma Chemical Co., St.
Louis, MO).

Plasma was collected by centrifugation at 1000

X gr for 12 min and analyzed for non-esterifled fatty acids
(NEFA; WAKO NEFA-C kit, WAKO Chemical USA, Dallas, TX) and

lactate (Sigma lactate kit 735-10).

Plasma samples were

frozen for later analysis of VFA (Quigley et al., 1991).
Metabolite Flux Calculations

Chronic indwelling catheters used in this study can be
used to calculate venoarterial differences by sampling
arterial blood supply and venous drain of specific tissue
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beds.

When concentrations of a specific metabolite are

higher in the arterial blood than in venous drain from a

given cissue, it may be said that the tissue is extracting
and possibly utilizing that metabolite.

However, if

concentrations of venous drain are greater than the arterial

input, the tissue is releasing and possibly biosynthesizing
that specific metabolite.

These venoarterial differences

were used in combination with blood flow rates through the
same tissues for calculations of net flux rates.

Metabolite

fluxes across PDV, hepatic, total splanchnic tissues, and
hindquarters were calculated by the following equations
(Heitmann, 1989):

Portal drained viscera flux = PF * (Cp - C^)

Hepatic flux = PF *

- Cp) + AF * (Cj^ - C^)

Total splanchnic flux = HF * (Cj^ - C^)
Hindquarter flux = VF * (C.^. - Cg^)
Where, PF, AF, HF and VF are whole blood or plasma flow

rates (1/min) through the portal vein, hepatic artery,
hepatic vein and caudal vena cava.

Metabolite

concentrations in these same vessels are indicated by Cp,
Cg, Cv, and C^, respectively.

Flux rates resulting in

positive numbers are indicative of synthesis of a metabolite
by that tissue.

Conversely, negative flux rates represent

an uptake or utilization of a metabolite by a tissue.
Ixtraction ratios for metabolites in specific tissues
were also calculated.

"Extraction ratios are that fraction
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of the metabolite presented to the tissue (tissue blood flow

multiplied by the concentration in the arterial input) that
is taken up by the tissue (net flux)" (Heitmann et al.,
1989).

Changes in extraction ratios are due to some

physiological mechanism and not solely to changes in
metabolite concentrations.

Statistical Analysis
Data were analyzed as a latin square using General

Linear Mixed Models software developed by Blouin and Saxton
(1990).

Treatment and period were used as rows and columns.

RESULTS

Splanchnic blood flow decreased (P < .05) 20 to 25%

with lasalocid supplementation, but portal flow continued to
represent 80 - 83% of the total splanchnic blood flow (Table

2).

There was a 12% increase in hindquarter flow when

lasalocid was added to the diet.

Arterial concentrations, veno-arterial differences and

hepatic-portal differences of energy metabolites measured
are in Table 3.

Lasalocid increased arterial concentrations

of acetate (P < .05) and tended to increase arterial

concentration of glucose (P < .10) and decreased circulating
concentrations of (L+)lactate (P < .01) and NEFA (P < .10)

by 27%.

In the case of NEFA n = 3 rather than 4 due to

missing data.
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Table 2. Blood flow rates across splanchnic and peripheral
tissues in sheep fed a forage based diet with or without
lasalocid.

Item

Hepatic

Hepatic Hind-

Portal

Hepatic

Portal

Artery

quarter

Flow

Flow

Ratio

Flow

Flow

l/h-

•1/hControl^

147.6

177.0

.83

32.4

82.8

Lasalocid

111.0

139.2

.80

28.2

93.0

se"

7.8

9.0

.04

6.0

1.8

p<d

.01

.01

NS

NS

.01

^0 mg/kg lasalocid

"44 mg/kg lasalocid

^Standard error of least squares mean, n = 4

"Probability that treatments differ
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Table 3.

Arterial concentrations, veno-arterial, and

hepatic-portal differences of energy metabolites in sheep

fed a forage based diet with or without lasalocid.
Item

Control^

Lasalocid^

SE^

P<^

Arterial concentrations, mM
Glucose
(L+)lactate

2.98
1.18

3.06

.05

.87

.08

.01

.174

.038

.10

.10

NEFA

.240

BOHB

.340

.311

.021

NS

ACAC

.026

.013

.004

.01

.08

.05

Acetate

1.20

1.39

Propionate

.037

.039

.004

NS

Butyrate

.027

.021

.003

.05

Isobutyrate

.006

.005

.0002

Valerate
Isovalerate

.000
.005

.001

.0003

.05

.007

.0004

.01

Portal-arterial difference.
Glucose

NS

mM

.001

.04

.02

NS

(L+)lactate

-.01

.06

.01

.01

NEFA

-.009

.004

.003

.01

BOHB

.096

.081

.006

NS

ACAC

.020

.017

.002

NS

Acetate

.88

1.18

.040

.01

Propionate

.31

.43

.016

.01

Butyrate

.083

.066

.004

.01

Isobutyrate

.012

.016

.002

.01

Valerate

.015

.014

.001

NS

Isovalerate

.016

.036

.001

.01

.13

.27

.02

.01

(L+)lactate

-.02

.05

.01

.01

NEFA

-.034

.006

.01

.01

Hepatic-arterial difference,
Glucose

mM

-.012

BOHB

.096

.061

.009

ACAC

.003

.003

.001

NS

Acetate

.777

.988

.031

.01

Propionate

.028

.038

.003

.10

Butyrate

.018

.017

.002

NS

Isobutyrate

.002

.001

.001

NS

Valerate
Isovalerate

.000
.002

.000

.000

.003

.0002

NS
.10
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Table 3. Continued

Lasalocid

Item

Control

Hepatic-portal

difference, mM

Glucose

.11

.23

SE

P<

.02

.01

(L+)lactate

- .00

- .01

.01

NS

NEFA

-.025

-.016

.006

NS

BOHB

.034

.026

.008

NS

ACAC

-.017

-.015

.001

NS

Acetate

- .105

-.190

.029

.05

Propionate

- .278

-.406

.014

.01

Butyrate

- .048

-.065

.003

.01
.01

Isobutyrate

-.010

-.015

.001

Valerate

-.015

-.015

.001

NS

Isovalerate

- .014

- .033

.001

.01

Caudal vena cava-arterial
Glucose

difference, mM

- .09

- .05

.04

NS

(L+)lactate

.13

-.01

.02

.01

NEFA

.010

.012

.004

NS

-.054

.010

NS

BOHB

-.065

ACAC

- .001

-.002

.010

NS

Acetate

- .404

-.454

.026

NS

Propionate

-.014

-.017

.002

NS

Butyrate

-.007

-.005

.002

NS

Isobutyrate

- .001

.000

.0002

NS

Valerate

.000

.000

.0000

NS

Isovalerate

.000

.000

.0000

NS

^0 mg/kg lasalocid

44 mg/kg lasalocid

^Standard error of least squares mean, n
Probability that treatments differ

= 4
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Concentrations of ACAC in arterial blood were reduced by 50%
with lasalocid addition.

Lasalocid supplementation resulted

in a decrease in the arterial concentrations of butyrate.
Concentrations of valerate decreased and isovalerate

increased statistically, however, this is probably of little
physiological consequence.
Portal-arterial differences were increased for all

measured VFA (P < .01) when lasalocid was added to the diet,

with the exception of valerate (P > .10) and butyrate.
Butyrate concentration decreased (P < .01) when lasalocid

was supplemented.

Differences in portal-arterial

concentrations of (L+)lactate were changed from a release

(positive) to an uptake (negative) (P < .01) with lasalocid
addition.

Portal-arterial concentration differences of NEFA

were changed from an uptake to a release (P < .01) with
lasalocid supplementation.

Hepatic-arterial difference of glucose was increased (P
< .01) 200%, and BOHB decreased (P < .01) 57% with lasalocid

addition.

Difference in hepatic-arterial concentrations of

NEFA were reduced (P < .01) by almost 65% when lasalocid was
added.

(L+)lactate hepatic-arterial difference was changed

(P < .01) from negative to positive when lasalocid was added
to the diet.

Hepatic-arterial differences were increased

(more positive) for the VFA, acetate (P < .01), propionate
(P < .10) and isovalerate (P < .10) with lasalocid

supplementation.
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Hepatic-portal concentration difference in glucose was
increased (more positive) two fold (P < .01) with lasalocid
addition.

Difference in hepatic and portal concentrations

of acetate was decreased (more negative) with lasalocid
supplementation.

Hepatic-portal differences decreased (P <

.01) (more negative) for propionate, butyrate, isobutyrate
and isovalerate when lasalocid was added.

Caudal vena cava-arterial differences were unchanged by
treatment for all metabolites except (L+)lactate.
(L+)lactate differences in caudal vena cava and arterial

concentrations were changed (P < .01) from a positive
production to a negative uptake when wethers were
supplemented with lasalocid.
Portal-drained viscera flux of (L+)lactate and NEFA was

changed (P < .01) from an uptake to a positive production
with lasalocid (table 4).

In the case of NEFA n = 3 rather

than 4 due to missing data.

Release of ACAC was decreased

(P < .01) by 50% when lasalocid was supplemented.

An

increased PDV release of propionate and isovalerate (P <

.01) was observed with lasalocid supplementation.
Hepatic glucose production was increased (P < .01) 57%

with lasalocid addition.

Decreased hepatic uptake of NEFA,

ACAC (P < .01) and valerate (P < .01) occurred with

lasalocid supplementation.

Hepatic production of BOHB
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Table 4. Splanchnic and peripheral fluxes and extraction
ratios of energy metabolites in sheep fed a forage based
diet with or without lasalccid.

Item

Control'

Lasalocid

SE'

P<^

Portal-drained viscera flux, mmol/h
Glucose

(L+)lactate

.60

4.40

4.31

NS

-1.45

6.96

2.98

. 01
. 01

NEFA

-.99

.17

.37

BOHB

11.29

9.48

1.68

NS

ACAC

4.15

2.33

0.50

, 01

Acetate

91.14

94.56

7.62

NS

Propionate

31.38

36.86

2.77

,05

Butyrate
Isobutyrate

6.88
1.28

6 43

.67

NS

1 35

.13

NS

Valerate
Isovalerate

1.42
1.61

1 22

.14

NS

2 87

.02

, 01

20.29

31.83

,37

. 01

-.46

.37

, 65

NS

NEFA

-3.61

-1.25

, 13

. 05

BOHB

11.26

6.81

,17

. 05

ACAC

-3.62

-1.87

,34

.01

Hepatic Flux, mmol/h
Glucose

(L+)lactate

Acetate

Propionate
Butyrate
Isobutyrate
Valerate
Isovalerate

7.26

7.08

58

NS

-27.97

-32.81
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NS

-4.65

-4.65

54

NS

-.99

-1.20

14

NS

-1.54

-1.21

14

,01

-1.35

-2.56

16

,01

Hepatic extraction ratios
NEFA

.10

13

0.02

NS

Propionate

.78

81

0.02

.10

Butyrate
Isobutyrate

.46
.50

53

0.04

.10

64

0.04

.10

Isovalerate

.61

72

0.01

,10
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Table 4 Continued

Item

Control

Lasalocid

SE

P<

Total splanchnic flux, mmol/h
Glucose

20.89

36.23

4.48

.01

(L+)lactate

-1.91

7.33

3.54

.01

NEFA

-4.60

-1.08

1.23

.01

BOHB

22.55

16.30

2.37

.01

.39

.46

.40

NS

98.40

101.64

6.90

NS

Propionate

3.41

4.05

.50

NS

Butyrate

1.79

2.40

.40

NS

ACAC
Acetate

Isobutyrate
Valerate
Isovalerate

.29

.15

.09

NS

- .12

.01

.06

.05

.25

.30

.07

NS

Hindquarter flux, mmol/h
Glucose

-7.33

-4.86

5.80

NS

(L+)lactate

12.70

-1.10

4.37

.01

NEFA

.51

.72

.45

NS

BOHB

-7.99

-5.31

1.78

.10

ACAC
Acetate

Propionate

-0.10

-.11

.38

NS

-24.24

-32.76

2.52

.01
NS

-1.03

-1.09

.15

Butyrate

-.52

-.38

.13

NS

Isobutyrate

-.03

-.03

.03

NS

Valerate
Isovalerate

-.03

.03

.04

NS

-.01

-.05

.02

.10

.39

.02

.10

Hindquarter extraction ratios
Acetate

.34

^0 mg/kg lasalocid

^44 mg/kg lasalocid

^Standard error of least squares mean, n = 4

^Probability that treatments differ
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declined by 40% when lasalocid was added to the diet.
Hepatic uptake of isovalerate increased (P < .01).
Hepatic extraction ratios increased (P < .10) with

lasalocid feeding for propionate, butyrate, isobutyrate, and
isovalerate.

Total splanchnic flux of VFA were unaffected by
treatment, with the exception of valerate which changed
uptake to release with lasalocid addition.

Lasalocid

supplementacion increased (P < .01) total splanchnic release

of glucose by 73% and changed (L+)lactate uptake to a
significant release (P < .01).

Uptake of NEFA by total

splanchnic tissue was declined with lasalocid addition.
Production of BOHB by total splanchnic tissues was reduced
(P < .01) by 28%. when lasalocid was supplemented.
Hindquarter flux of (L+)lactate was changed (P < .01)

from release to uptake with lasalocid supplementation.
Lasalocid supplemented wethers had reduced (P < .10) uptake
of BOHB by hindquarter tissue.

Uptake of acetate by

peripheral tissues was increased (P < .01) by 35% when
wethers received supplemental lasalocid.

All other VFA were

unaffected by treatment except isovalerate, which showed

increased hindquarter utilization with lasalocid addition.
Hindquarter extraction ratio of acetate was increased
(P < .10) with lasalocid supplementation.
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DISCUSSION

Concentrations of energy metabolites taken from single

site peripheral locations, such as a jugular vein, provide
only limited information on metabolic activity of an animal

(Heitmann, 1989).

Concentration of a metabolite at any

given time is a function of the rate of appearance and
disappearance.

The rate of appearance of a metabolite is a

function of its de novo synthesis and release by a tissue

and/or its absorption from the alimentary tract.

For

example rate of appearance is a function of VFA, endogenous
synthesis of glucose or ketone bodies, or a combination of

the two, as in NEFA.

Disappearance of a given metabolite is

a function of excretion, oxidation or interconversion.

Multisite sampling used in this study make possible the
calculation of specific fluxes of metabolites.

Differences

in veno-arterial concentrations are indicative of changes in
splanchnic and peripheral tissue uptake or releases of a

metabolite.

Portal-arterial difference represents 100% of

portal-drained viscera flux, hepatic-arterial differences

make up approximately 20% of liver flux with the remaining
percentage represented by hepatic-portal differences (see

hepatic/portal ratios in Table 2).

Caudal vena cava-

arterial differences represent 100% of the hindquarter flux.

However, it should be noted that the hindquarter preparation
used in this experim.ent is a combination of muscle and
adipose tissues, with skin, bone and other tissues also
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contributing to the observed rates of flux.

Although veno-

arterial differences provide additional information on total

body metabolism as compared to single site sampling,
misinterpretations may occur.

Using veno-arterial

differences in combination with blood flow rates across

specific tissues one can calculate rates of flux of a
metabolite across tissue beds.

The observed changes in splanchnic peripheral blood
flows (Table 2) in wethers supplemented with lasalocid may

indicate a "fight or flight" syndrome (G.B. Huntington,
personal communication).

In contrast to reports using

monensin (a monovalent ionophore), lasalocid (a divalent ion
transporter), increases the release of epinephrine by
chromaffin cells (Hochman and Perlman, 1976).

Therefore,

epinephrine induced changes in blood flow rates could

explain the observed shift in blood flow from splanchnic to
peripheral tissues in wethers supplemented with lasalocid.
Increased arterial concentrations of glucose with
lasalocid feeding was due to increased hepatic production

and similar rates of hindquarter uptake.

Increased hepatic

production of glucose was despite the observed decrease in
splanchnic blood flow.

These results are in contrast with a

previous report by Harmon et al. (1993), which found no

change in hepatic release of glucose in ruminants
supplemented with monensin.

Increased production of glucose

by liver tissue could be the result of two factors; an
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increased hepatic uptake of gluconeogenic precursors or
increased gluconeogenic activity of the tissue by direct

action of the ionophore or an ionophore mediated change.
Benz et al. (1989) showed decreased levels of fructose

2,6-bisphosphate on liver tissue when animals were
supplemented with ionophore.

These researchers concluded

that the observed decrease in fructose 2,6-bisphosphate and
decreased lactate:pyruvate ratio was indicative of increased
gluconeogenic activity of the liver.

Hers and Van

Schaftingen (1982) found fructose 2,6-bisphosphate to be an
important metabolite in terms of shifting glucose metabolism
towards glycolysis and away from gluconeogenesis.
Therefore, decreased levels of fructose 2,6-bisphosphate

would favor the gluconeogenic pathway.
Increased hepatic glucose release observed in this

experiment are consistent with depressed levels of fructose
2,6-bisphosphate.

Increased release of epinephrine in

response to lasalocid (Hochman and Perlman, 1976) could
explain decreases in fructose 2,6-bisphosphate observed by

Benz et al. (1989). Epinephrine induces activation of cAMPprotein kinase and subsequent inactivation fructose 2,6bisphosphate kinase, the enzyme responsible for the

formation of fructose 2,6-bisphosphate.
Although propionate uptake by the liver was similar

between controls and lasalocid supplemented animals, the
hepatic extraction ratio was increased with lasalocid
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addition, suggesting an increase in hepatic gluconeogenic
activity.

If it is assumed that all of the propionate taken

up by the liver is converted to glucose, then 66% of the
total hepatic glucose production can be explained by
propionate in control animals.

Hepatic glucose production

decreases to 52% in wethers supplemented with lasalocid.
Glucose production by liver tissue was increased by 11.5

mmol/h when lasalocid is supplemented.

Propionate uptake by

the liver can account for 2.42 mmol/h [(32.81 - 27.97)/2] or

21% of this increase with approximately 8 mmol/h unaccounted
for.

A possible source of this glucose may be through

increased portal concentrations and subsequent hepatic
uptake of gluconeogenic amino acids.

Previous research has

indicated that approximately 2 moles of glucose can be
obtained or synthesized by uptake of alanine and glutamine
in a fed sheep (Bergman and Heitmann, 1978), Harmon et al.
(1993) found no change in PDV release or hepatic uptake of
a-amino nitrogen with monensin supplementation in steers,
indicating similar total amino acid flux through these

tissues.

lonophores have been shown to decrease rumen

proteolysis while maintaining total nitrogen flow to the
abomasum (Schelling, 1984; Poos et al., 1979) which

increased proportions of feed nitrogen appearing in the
abomasum.

These studies would indicate total amino acid

available for absorption in the small intestine does not
change and PDV release of Q;-amino nitrogen would not be
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expected to change.

Thus, a shift in individual amino acids

released by PDV may occur in wethers supplemented with
lasalocid, such that increased proportions of gluconeogenic

amino acids are available for hepatic uptake and subsequent
conversion to glucose.
Increased release of (L+)lactate and propionate by PDV
(Table 4) in wethers receiving lasalocid differ with
previous reports in steers supplemented with monensin
(Harmon et al. 1989 and Harmon et al., 1993), wherein no

changes in propionate or (L+)lactate release by PDV were
observed.

The researchers proposed preferential use of

propionate over glucose by gut tissue for energy because
release of glucose by PDV was increased in this study.
Observed decreases in arterial concentration of ACAC

are a result of a reduction in PDV release, due to decreased

blood flow and not a decrease in portal-arterial
differences.

Although production of BOHB by PDV tissue was

unaffected by treatm.ent a reduction in hepatic ketogenesis
was observed.

The major precursors of hepatic BOHB

production measured in this experiment were ACAC, NEFA and

butyrate.

Acetoacetate is taken up by hepatic tissue in fed

ruminants, but only for conversion to BOHB (Heitmann et al.,
1987).

Wethers supplemented with lasalocid had decreased

uptake of ACAC and NEFA while butyrate uptake was unaffected
by lasalocid addition; therefore, a subsequent decrease in
hepatic release of BOHB was expected.

However, other
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reports (Harmon et al., 1993) found no change in hepatic
ketogenesis when steers were supplemented with monensin and

no change in BOHB precursors taken up by hepatic tissue.
Decreased hepatic production of BOHB is primarily due
to the decrease in BOHB that could have been derived from

NEFA.

Wethers fed control diets had a hepatic release of

11.26 mmol/h of BOHB and an uptake of 3.62 mmol/h of ACAC.
Therefore, 32% of BOHB production can be explained by ACAC
uptake.

Wethers supplemented with lasalocid had a PDV

release of 6.81 mmol/h BOHB while taking up 1.87 mmol/h
ACAC.

In this case 27% of BOHB production can be explained

by ACAC uptake.

Because ACAC can be converted only to BOHB

by hepatic tissue this leaves 7.64 mmol/h unexplained BOHB

being produced by the liver in controls and 4.94 mmol/h
unaccounted for in wethers supplemented with lasalocid.

If

it is assumed that 4.25 moles of BOHB can be produced by 1
mole of NEFA (assuming a 17 carbon average) then 15.34

mmol/h or 200% of remaining BOHB can be explained by NEFA
uptake in controls.

Using the same assumptions 5.31 or 107%

of the remaining BOHB released by hepatic tissue in wethers
supplemented with lasalocid can be explained by NEFA uptake.
These data suggest a decrease in oxiation of NEFA and
butyrate.

Decreases in these metabolic pathways may result

in a reduced availability of NADH used in synthesis of

glucose.

As discussed earlier, hepatic glucose production

was increased with lasalocid supplementation.

It is unclear
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where the additional NADH is produced.

Possibly increased

hepatic glucose production when lasalocid is added is a
result of changes in individual amino acid proportions taken
up by the liver.

Another explanation could be the

interconversion of lactate and pyruvate.

However, since

neither amino acids nor pyruvate were analyzed in this study
these explanations are unsupported.
A comparison of portal energy flux (Table 5) between
treatments shows similar energy release between treatments,
however, a shift in energy metabolites release is apparent.
When lasalocid was added to the diet, energy released in the

form of glucose and propionate increased.

More notably,

percent energy released in the form of ketone bodies from
PDV in wethers supplemented with lasalocid was decreased.
Lasalocid addition to forage based diets increased
hepatic gluconeogenic potential and altered blood flow rates
through splanchnic tissues.

These results support earlier

research which identified increased epinephrine release with
divalent ion transporters.

Notably, a decrease in hepatic

BOHB production was seen primarily due to decreased NEFA
uptake by the liver.

49

Table 5. Distribution of portal drained viscera energy flux
in animals fed a forage based diet with or without
lasalocid.^

Item

Control

Lasalocid

Portal energy flux. kcal/d (% of total)
Glucose

3.31

L(+)lactate

.00
149.60

BOHB

ACAC

47.97

Acetate

458.19

Propionate

274.88

Butyrate

91.15

Isobutyrate

17.00

Valerate
Isovalerate

23.11

Total

26.12

(0.9)
(0.0)
(13.6)
(4.4)
(41.8)
(25.1)
(8.3)
(1.6)
(2.1)
(2.4)

1191.85

Total/ME intake

.29

(5.7)
(0.3)
125.58 (10.5)
26.94
(2.3)
475.34 (39.9)
322.88 (27.1)
85.17
(7.2)
17.88
(1.5)
(1.7)
19.85
46.66
(3.9)
68.27
3.28

1097.33
.27

^Values calculate from portal drained viscera flux using

heats of combustions (kcal/mole); glucose, 464.5; lactate,
326.8; BOHB, 552; ACAC, ; acetate, 209.4; propionate, 365;

4 carbon VFA, 552; 5 carbon VFA, 678.

"O mg/kg lasalocid

*^44 mg/kg lasalocid
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CHAPTER IV

ALTERATIONS OF ENERGY METABOLISM IN RUMINANTS FED A
CONCENTRATE BASED DIET WITH OR WITHOUT LASALOCID
INTRODUCTION

Addition of polyether ionophore antibiotics such as

lasalocid has become common practice in cattle finishing
operations.

Ionophore supplementation increases average

daily gain in steers on high grain diets without increased

feed intake, resulting in increased feed efficiency (Bergen
and Bates, 1984).

Reports of changes in rumen fermentative

end products have shown increased proportions of propionate
with reductions of acetate and butyrate (Richardson et al.,
1976; Thornton et al., 1976; van Maanen et al., 1979 and

Bartley et al., 1979).

Bergen and Bates (1984), concluded

that observed changes in proportions of ruminal VFA could

not completely account for the increased feed efficiency in
finishing steers.

Previous research has evaluated changes that occur in
ruminal fermentation with ionophore feeding and changes
occurring in metabolites released by portal-drained viscera
(PDV) in ruminants fed a concentrate based diet (Harmon and

Avery 1987; Harmon et al., 1988; 1989).

These researchers

reported changes in energy metabolite flux that may affect

energetic efficiency of an ionophore supplemented animal.
Currently there are no data available to describe
changes in hepatic energy fluxes in ruminants fed a
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concentrate based diet supplemented with lasalocid.

Lasalocid elicits changes in rumen VFA proportions similar
to monensin.

Benz et al. (1989) found lasalocid to be more

potent than monensin in changing hepatic gluconeogenic
intermediates in liver tissue.

The objective of the

present study were to determine changes in PDV and hepatic
net energy flux in wethers consuming a concentrate based
diet supplemented with lasalocid.

MATERIALS AND METHODS

Animals

Four weaned wethers (average BW = 63 ± 6 kg) were used

in a balanced 2x2 Latin Square to evaluate effects of
lasalocid addition to a concentrate diet on splanchnic
energy metabolism.

Animals were allotted randomly to

treatment and housed in individual 1.8 x 3.0 m pens
contained in a room with natural lighting. Ambient
temperature was maintained between 17 and 25°C.

Wethers

were allowed free access to fresh water.

Surgical Procedure

Wethers were transported to the experimental facility
at least 5 d prior to surgery for acclimation to the
facility.

Feed was removed 24 h and water removed 12 h

prior to surgery.

Surgical procedures were conducted as
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described by Katz and Bergman (1969), with modifications
made by by Zanzalari et al. (1989).

Chronic indwelling

catheters were placed in the portal, hepatic, mesenteric
veins, and caudal aorta.

A broad spectrum antibiotic was

given immediately following surgery and once daily for 3 d.
Animals were allowed 14 d for recovery during which body
temperature and wound healing were monitored daily.

Diets

Alfalfa pellets (17% CP) and steam rolled corn (10.1%

CP) were mixed on a dry matter basis (determined by forced
air oven drying at 5G°C) 25% and 75% respectively (Table
1).

Animals were fed 1.5 leg in one feeding (0800 h).

Nutrient consumption exceeded the NRC requirements for CP
for post weaning wethers (NRC, 1985).

Wethers were allowed

free access to trace mineral salt blocks throughout the

experiment.

Two treatments were utilized; concentrate

based diet with or without supplemental lasalocid.

Liquid

lasalocid (Hoffman-LaRoche, Princeton, NJ) was supplemented

at 44 mg/kg by daily addition to feed.

Blood Sampling
Treatment periods were 12 d, with blood collection on

d 12.

Blood sampling was preceded by a primed, continuous

infusion of para-aminohippurate (PAH, 1.5% @ .764 ml/min)
into a mesenteric vein.

Following a 1 h equilibration
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Table 1.

Analysis of concentrate based diet fed with or

without lasalocid.

Item

Control

Lasalocid

DMI (kg/d)

1.5

1.5

ME (Mcal/d)

4.5

4.5

CP (g/d)

Requirement®'

4.4

185.0

185.0

181.0

Ca (mg/d)

5.8

5.8

5.7

P (mg/d)

4.9

4.9

3.0

Lasalocid

(mg/d)

0

66

TM salt

(free choice)

NRC. 1985.

Nutrient requirements of sheep. 6th revised

ed.

bComposition of TM salt block: NaCl, not more than 99%,
not less than 95%; Zn, not less than .35%; Fe, not less
than .34%; Mn, not less than .20%; Cu, not less than
.033%; I, not less than .007%; Co, not less than ,005%.

54

period, 12 ml blood samples were collected simultaneously
from the portal and hepatic veins, and caudal aorta.

was sampled at 30 min intervals (0900 to 1130 h) .

Blood

Samples

were collected in syringes pretreated with Na-EDTA (6% w/v)

as an anticoagulant.

Catheter patency was maintained

between samples and during treatment periods using Na-EDTA
(6% w/v).

Laboratory Analysis

Whole blood samples were analyzed within 24 h for PAH

(Kaufman and Bergman, 1971), S-hydroxybutyrate (BOHB) and
acetoacetate (ACAC) (Williamson and Mellanby, 1965), and

glucose (Sigma glucostat 510 kit, Sigma Chemical Co., St.
Louis, MO).

Plasma was collected by centrifugation at 1000

X g for 12 min and analyzed for non-esterifled fatty acids
(NEFA; WAKO NEFA-C kit, WAKO Chemical USA, Dallas, TX) and

L(-)lactate (Sigma lactate kit 735-10).

Plasma samples

were frozen for later analysis of VFA (Quigley et al.,
1991).

Metabolite Flux Calculations

By utilizing chronic indwelling catheters it was

possible to calculate of venoarterial differences by
sampling arterial blood supply and venous drain of specific
tissue beds.

When concentrations of a specific metabolite

are higher in the arterial blood than in venous drain from
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a given tissue, it may be said that the tissue is

extracting and possibly utilizing that metabolite.
However, if concentrations of venous drain are greater than

arterial input, the tissue is releasing and possibly
biosynthesizing that specific metabolite.

These

venoarterial differences were used in combination with

blood flow rates through the same tissues for calculations
of net flux rates.

Metabolite fluxes across PDV, hepatic,

total splanchnic tissues, and hindquarters were calculated
by the following equations (Heitmann, 1989):

Portal drained viscera flux = PF * (Cp - C^)
Hepatic flux = PF * (C^ - Cp) + AF * (Cj^ - C^)
Total splanchnic flux = HF *

- C^)

Where PF, AF, and HF are whole blood or plasma flow rates

(1/min) through the portal vein, hepatic artery, and
hepatic vein.

Metabolite concentrations in the same

vessels are indicated by Cp, C^, and C^, respectively.
Flux rates resulting in positive numbers are indicative of
synthesis of a metabolite by that tissue.

Conversely,

negative flux rates represent an uptake or utilization of a
metabolite by a tissue.

Extraction ratios for metabolites in specific tissues
were also calculated.

"Extraction ratios are that fraction

of the metabolite presented to the tissue (tissue blood
flow multiplied by the concentration in the arterial input)

that is taken up by the tissue (net flux)" (Heitmann et
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al,, 1989).

Changes in extraction ratios are due to some

physiological mechanism and not solely to changes in
metabolite concentrations.

Statistical Analysis
Data were analyzed as a latin square using General

Linear Mixed Models software developed by Blouin and Saxton
(1990).

Treatment and period were used as rows and

columns.

RESULTS

Splanchnic blood flow decreased (P < .10) 11 to 16%

when lasalocid was fed.

Portal blood flow represented 78-

80% of the total splanchnic blood flow rate (Table 2).

Hindquarter blood flow was not measured in this experiment
due to catheter patency, but if cardiac output remained
similar, hindquarter flow would have increased as in trial
1.

Arterial concentrations of BOHB decreased (P<.01) by
27% when lasalocid was added but arterial concentrations of

no other metabolites were affected (Table 3).

Glucose portal-arterial (PA) difference increased two
fold and NEFA PA increased (P < .10) four fold when

lasalocid was supplemented.

Valerate PA concentration

increased (P < .10) when lasalocid was added.

Portal-

arterial differences of BOHB, isobutyrate and isovalerate
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Table 2.

Blood flow rates across splanchnic tissues in

sheep fed a concentrate based diet with or without
lasalocid.

Item

Portal

Hepatic

Flow

Flow

Hepatic

Hepatic

Portal

Artery-

Ratio

Flow

-1/h

1/h

Control^

130.2

163.2

.80

33.6

Lasalocid^

109.2

145.2

.78

36.0

SE^

6.0

7.8

.12

4.8

P<^

.01

.10

NS

^0 mg/kg lasalocid

^44 mg/kg lasalocid

rStandard error of least squares mean, n = 4
Probability that treatments differ

NS
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Table 3.

Arterial concentrations, veno-arterial, and

hepatic-portal differences of energy metabolites in sheep

fed a concentrate based diet with or without lasalocid.

Item

Control^

Lasalocid^

SE^

P<'^

Arterial concentrations, mM
Glucose

3.18

3.09

.08

NS

L{+)lactate

1.04

.99

.08

NS

NEFA

.190

.291

.022

NS

BOHB

.420

.305

.030

.01

.006

NS

.07

NS

ACAC

.030

Acetate

. 874

Propionate

.042

.026

.012

NS

Butyrate

.017

.021

.003

NS

.030
1.11

Isobutyrate

.004

.004

.0006

NS

Valerate

.000

.000

.0001

NS

Isovalerate

.006

.002

.0010

NS

.05

.11

.02

L(+)lactate

.04

.08

.02

NEFA

.003

.012

.004

.10

BOHB

.165

.134

.011

.05

ACAC

.042

.005

NS

.069

NS

Portal-arterial
Glucose

Acetate

difference.

mM

.038

1.35

1.19

.05

NS

Propionate

.532

.516

.025

NS

Butyrate

.064

.056

.004

NS
.01

Isobutyrate

.011

.008

.006

Valerate

.013

.015

.007

.10

Isovalerate

.024

.010

.001

.01

Hepatic-arterial difference.

mM

Glucose

.24

.31

.02

.05

L{+)lactate

.01

.07

.02

.10

NEFA

-.020

-.021

.004

NS

BOHB

.184

.182

.010

NS

ACAC

.010

.004

.004

NS

Acetate

.903

.902

.070

NS

Propionate

.061

.051

.006

NS

Butyrate

.013

.020

.002

.05

Isobutyrate

.002

.001

.0004

.01

Valerate
Isovalerate

.002

.001

.0004

NS

.001

.001

.0004

NS
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Table 3. Continued
Item

Hepatic-portal difference,
Glucose

Lasalocid

Control

SE

P<

mM

.20

.20

.02

NS

L(+)lactate

- .03

-.01

.01

NS

NEFA

-.023

- .034

.006

NS

BOHB

.031

.034

.002

NS

ACAC

- .033

- .048

.007

NS

Acetate

-.287

-.443

.065

.01

Propionate
Butyrate
Isoh5utyrate

-.465

- .472

.024

NS

- .043

-.044

.003

NS

- .009

- .007

.001

.01

Valerate
Isovalerate

-.012

-.014

.001

.01

-.023

-.009

.001

.01

^0 mg/kg lasalocid

°44 mg/kg lasalocid

^Standard error of least squares mean, n = 4
Probability that treatments differ
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were reduced (P < .05) when wethers were supplemented with
lasalocid.

Differences in hepatic-arterial (HA) concentrations of

glucose increased (P < .05) (more positive) when wethers
were fed lasalocid (Table 3).

Supplementation with

lasalocid caused a five fold increase in HA difference of

L(+)lactate (P < .10).

An increase of 55% in HA butyrate

was also observed with lasalocid addition.

Isobutyrate was

the only metabolite with reduced (P < .01) HA difference
due to lasalocid supplementation.
Hepatic-portal (HP) difference of acetate was reduced

(P < .10) (more negative) by approximately 54% with
lasalocid supplementation (Table 3).

This decrease (P<

.01) was also observed in valerate and isobutyrate HP
difference when lasalocid was added.

An increase in HP

difference of isovalerate (P < .01) was observed in wethers

supplemented with lasalocid.

Splanchnic flux rates and extraction ratios of energy
metabolites measured are in table 4.

Glucose and NEFA

release were increased by more than two fold (P < .05) by
PDV when wethers were supplemented with lasalocid.

Release

of BOHB, isobutyrate and isovalerate by PDV decreased (P <
.01) when wethers were supplemented with lasalocid.
Hepatic L(+)lactate flux was changed (P < .10) from an
upta)ce (negative) to a production (positive) when lasalocid
was supplemented on a concentrate based diet (Table 4).
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Table 4.

Splanchnic fluxes and extraction ratios of energy

metabolites in sheep fed a concentrate based diet with or
without lasalocid.

Item

Control^

p<d

Lasalocid

Portal-drained viscera flux, mmol/h
Glucose

4.96

12.75

2.41

L(+)lactate

6.33

9.34

1.95

NS

NEFA

.30

.76

.35

.05

BOHB

21.74

15.17

1.69

.01

ACAC

5.49

3.97

0.73

NS

109.38

100.86

9.48

NS

48.42

44.93

1.92

NS

Butyrate

5.53

4.72

.52

NS

Isobutyrate

1.15

.59

.10

.01

Valerate
Isovalerate

1.24

1.10

.13

NS

3.08

.76

.28

.01

Acetate

Propionate

.05

Hepatic Flux, mmol/h
Glucose

34.56

31.75

3.81

NS

L(+)lactate

-3.77

.41

1.95

.10

NEFA

-3.70

-2.97

.51

NS

BOHB

7.86

11.16

1.80

NS

ACAC

-3.91

-3.43

.84

NS

Acetate

-3.06

-6.42

7.92

NS

-42.48

-36.96

4.68

NS

-3.99

-3.03

.65

NS

NS

Propionate
Butyrate

Isobutyrate

-.79

- .53

.10

Valerate
Isovalerate

-1.07

-1.04

.15

NS

-2.89

- .67

.29

.01

Hepatic extraction ratios
NEFA

.13

.06

0.01

.01

Propionate

.77

.72

0.02

NS

Butyrate

.52

.46

0.03

NS

Isobutyrate

.46

.45

0.18

NS
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Table 4 Continued

Item

Control

Lasalocid

SE

P<

Total splanchnic flux, mmol/h
Glucose

L(+)lactate

39.52

44.50

3.84

NS

2.56

9.75

3.48

.10

NEFA

-2.40

-2.21

.46

NS

BOHB

29.60

26.33

2.83

NS

ACAC

1.58

.54

.82

NS

106.38

94.44

7.86

NS

Propionate

6.09

5.92

.59

NS

Butyrate

1.54

1.70

.22

NS

Acetate

Isobutyrate

.35

.05

.05

.01

Valerate
Isovalerate

.17

.06

.04

NS

.35

.09

. 05

NS

^0 mg/kg lasalocid

44 mg/kg lasalocid

^Standard error of least squares mean, n
Probability that treatments differ

= 4
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Hepatic uptake of isovalerate was decreased (less negative)
with lasalocid addition.

Hepatic extraction ratio of NEFA was decreased (P <

.01) by 50% when lasalocid was fed; the remaining hepatic
extraction ratios were unchanged between treatments.
Release of L(+)lactate by total splanchnic tissues was
increased (P < .10) almost four fold with lasalocid

supplementation (Table 4).

The only other observed change

in total splanchnic energy flux was a decline (P < .01) in
isobutyrate release when lasalocid was supplemented.

DISCUSSION

Arterial concentrations of BOHB decreased in lasalocid
fed animals as a result of decreased PDV release.

A

decrease in the proportion of ruminal butyrate would reduce
PDV production of BOHB.

Pennington and Pfander (1956) and

Weigand et al. (1972) reported that between 75 and 82% of
butyrate absorbed by rumen epithelium is converted to BOHB.
Previous reports have indicated a depression in proportions
of butyrate in the rumen with ionophore supplementation
(Richardson et al., 1976; Thornton et al., 1976; Bartley et

al., 1979).

Therefore, decreased BOHB release by PDV was

consistent with previously reported VFA changes.
Release of glucose by PDV was greater with lasalocid
addition to a concentrate based diet but not a forage based
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diet (Trial 1).

This agrees with previous reports in

steers fed a concentrate based diet (Harmon et al., 1989).

It has been suggested that increased release of glucose by

PDV may indicate a shift in the major metabolite used by
PDV for energy (i.e. from glucose to propionate) (Harmon et
al., 1988; 1993).

Harmon et al. (1993) suggested that the

antibacterial activity of ionophores may spare glucose from
microbial breakdown, making it more available to the small
intestine, and ionophore induced changes in rumen VFA with

ionophore supplementation may provide more propionate which
is preferred as an energy substrate.

Harmon et al. (1991)

reported that rates of propionate oxidation in rumen

papillae slices were 2 to 9 times higher than glucose
oxidation.

Their data suggest a preferential use of

propionate by gut tissue for energy in lieu of extracting
arterially supplied glucose.

This hypothesis is also

supported by lack of change in PDV propionate observed in
this experiment and other reports by Harmon and Avery
(1987) and Harmon et al. (1989).

L(+)lactate release by

PDV was similar between treatments indicating that if

propionate utilization by PDV is increased with lasalocid
supplementation the major metabolic end product is not
lactate.

Increased utilization of propionate by PDV is

assumed to be due to increased rumen concentrations of

propionate and lack of observed increases in PDV release of
propionate (Harmon et al., 1993).

Weigand et al. (1972)
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reported only 5% of absorbed propionate was converted to
lactate in rumen epithelium of calves.

Harmon et al.

(1991) found rates of oxidation of propionate to CO2 3 to 5
times higher than propionate conversion to lactate in rumen
papillae slices.

These data would indicate that the

primary route for propionate metabolism in PDV is oxidation

to CO2.
Release of the branched chain VFA by PDV was decreased
as in previous studies with steers receiving concentrate

based diets (Harmon and Avery, 1987).

However, these rates

are small and may not be physiologically significant.
Hepatic flux of lactate was shifted from uptake to
production in wethers fed lasalocid resulting in subsequent
increases in total splanchnic production.

These results

differ from previous results by Harmon et al. (1993) who
found no change in hepatic or total splanchnic flux of
lactate when steers were fed a high forage diet with
monensin.

A comparison of total net energy production from PDV

tissues shows similar total energy release (Table 5).
Animals supplemented with lasalocid showed a decreased
proportion of energy explained by ketone bodies.

Additionally, energy available from glucose was also
higher.

Wethers supplemented with lasalocid had decreased

percentages of energy represented by the VFA, acetate.
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Table 5.

Distribution of portal drained viscera energy

flux in animals fed a concentrate based diet with or

without lasalocid.^

Item

Lasalocid

Control

Portal energy flux. kcal/d (% of total)
Glucose

2.30

L(+)lactate

2.98

BOHB

287.98

ACAC

63.50

Acetate

549.70

Propionate

424.17

Butyrate
Isobutyrate

18.18

Valerate

20.21

Isovalerate

50.18

Total

Total/ME intake

73.29

(0.2)
(0.2)
(19.3)
(4.3)
(36.9)
(28.5)
(4.9)
(1.2)
(1.4)
(3.4)

5.92
4.40

201.00
45.93

506.87
312.73
62.56
7.79

17.96
12.40

1489.49

1177.56

.31

.24

(0.5)
(0.4)
(17.2)
(3.9)
(43.0)
(26.6)
(5.3)
(0.7)
(1.5)
(1.1)

^ Values calculate from portal drained viscera flux using

heats of combustions (kcal/mole); glucose, 464.5; lactate,

326.8; BOHB, 552; ACAC, ; acetate, 209.4; propionate, 365;
^4 carbon VFA, 552; 5 carbon VFA, 678.

^0 mg/kg lasalocid

'44 mg/kg lasalocid
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propionate and butyrate although total energy released into
portal circulation was unaffected by treatment.
The shift in blood flow rates are consistent with

trial 1.

As in trial 1, splanchnic blood flow declined

with lasalocid supplementation.

These results support

previous results that indicate a shift in the major
metabolite used for energy by PDV tissue.

This appears to

be an increase in the use of propionate and away from use
of glucose.

As in trial 1, lasalocid decreased

ketogenesis; however, in wethers fed a concentrate based

diet a decrease was seen in PDV production of ketones with
no observed changes in hepatic ketogenesis.
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CHAPTER V

ALTERATIONS OF VFA METABOLISM IN RUMEN EPITHELIAL SHORT
TERM CELL INCUBATES IN WETHERS FED A FORAGE BASED
DIET WITH OR WITHOUT LASALOCID
INTRODUCTION

Lasalocid is a polyether ionophore antibiotic that
transports divalent cations across cell membranes.

Supplementation with ionophores resulted in an increased
rumen molar proportions of propionate and decreased molar
proportions of acetate and butyrate (Richardson et al.,
1976; Thornton et al., 1976; Hartley et al., 1979).
More recent reports have evaluated changes in energy
metabolite fluxes in portal-drained viscera (PDV) with

ionophore feeding (Harmon and Avery, 1987; Harmon et al.,
1988; 1989; 1993).

These reports and data from trials 1

and 2 of this study indicate a possible change in the use
of glucose, propionate and ketones by PDV tissue.

Portal-

drained viscera tissue may use more propionate and ketones
for energy while sparing glucose from oxidation.

This

shift in metabolism is more dramatic in ruminants fed a

forage based diet (Harmon et al., 1993).

Data from trial 2

support previous studies indicating increased glucose

release by PDV tissue when ruminants are supplemented with
ionophores.

There are no published reports evaluating ionophore
supplementation on VFA metabolism by isolated rumen
epithilial cells.

Because rumen epithelium would
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significantly contribute to metabolite flux in PDV

measurements and are the first tissue exposed to ionophores
supplemented in the diet, an evaluation of the effect of

ionophores on rumen tissue would be valuable in improving
our understanding of the changes observed when ionophore
supplementation occurs.

MATERIALS AND METHODS

Animals and Diets

Five wethers (average BW 65 ± 7 kg) were used in this
study.

Animals were housed in individual 1.8 x 3.0 m pens

in a room where ambient temperature was maintained between
22 and 25°C.

Wethers were fed 2.0 kg/d of a diet

consisting of 75% alfalfa pellets and 25% rolled corn.
Animals were randomly allotted to either control (0 mg

lasalocid/kg; n=2) or lasalocid supplemented (44
mglasalocid/kg; n=3).

Liquid lasalocid was given at each

feeding by top-dressing and mixing to ensure total intake.

Rumen Epithelial Cell Isolation

Rumen epithelial cells were isolated using the
procedures of Baldwin and Jesse (1991).

Five cell

collections were made under USDA inspection at the

University of Tennessee Meats Laboratory located in the
Food Science and Technology Department.

Following
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exsanguination, approximately an 8 cm^ portion of the
ventral cranial sac of the rumen was excised.

Adherent

feed particles were removed with 37°C tap water.

The

tissue was placed in a 37°C isotonic wash buffer of Krebs

Ringer salts (KRB) (.3239 g KH2PO4; .5866 g MgS04-7H20;
.706 g KCl; 14.4 g NaCl), plus 25 mM N-2-

hydroxyethylpiperazine-N'-2 ethane sulfonic acid, pH 7.4)
(KRBHEPES) and quiclcly transported to the laboratory.

The

muscle layer was removed and the epithelial tissue was
diced with a scalpel to increase surface area for maximum
exposure to trypsin digestion.

The tissue was maintained

at 37°C in KRBHEPES for the entire isolation procedure.

A

10 g sample of diced papillae was added to a digestion

solution consisting of 2% trypsin and .25 mM CaCl2
dissolved in KRBHEPES and placed in a rotary hot air
incubator and maintained at 37°C while being gently
stirred.

Digestions continued for 15 min.

After

incubation the solution was filtered through 500 /xm nylon
mesh.

Tissue remaining on the mesh filter was rinsed with

KRBHEPES to remove digested material and added back to the
2% trypsin KRBHEPES for further digestion.
was repeated 5 to 7 times.

This procedure

The filtrate was collected in

50 ml conical tubes and centrifuged at 65 x g for 6 min.
This initial pellet was washed three times by resuspension
in 37°C KRBHEPES and recentrifuged.

Cells from the first

two digestions were discarded due to high concentrations of
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keratinized cells.

Cells obtained from the third and later

digestions were inspected visually and the highest quality
digests (usually digests 4 and 5) were combined and used in
the incubation procedure.

Cell viabilities were estimated by trypan blue
exclusion.

Briefly, 100 /il of the cell suspension was

added to an equal volume of 0.2% trypan blue dye and
incubated at room temperature (approximately 28°C) for
exactly four minutes.

A sample of this mix was placed on a

hemacytometer and cells were counted to establish number

and percent viability of cells.

Cell numbers were adjusted

such that a minimum concentration of 1 million viable cells

per ml were added to incubation flasks.

was accomplished in KRBHEPES at 37°C.

Dilution of cells

Average cell

viability for the tissue collections was 77 ± 3%.

Incubations

Incubations were initiated by the addition of 1 ml of
cells to a 25 ml Erlenmeyer flask containing 2.6 ml
KRBHEPES and 2.4 ml of VFA and albumin so that the final

concentrations were 50 mM acetate, 10 mM propionate, 5 mM

butyrate and 0.25 mM albumin.

These VFA levels closely

approximate the molar concentrations found in the rumen
(Baldwin and Jesse, 1991).

Incubations took place in a rotary constant
temperature incubator (New Brunswick Scientific, Edison,

12

NJ) at 37°C.

Incubations were terminated using 0.4 ml

concentrated perchloric acid and buffered with 0.8 ml

saturated potassium carbonace.

Five incubations were

terminated at time 0 and five additional incubations were
terminated at 30 min intervals to a final time of 120 min.

Analytical Techniques

The incubation mixture was centrifuged at 1500 x g for
15 min and supernatant was collected and centrifuged at
1500 X g for 15 min and subsequently assayed for ketone

bodies using the procedure of Williamson and Mellanby
(1974) and L-lactate and pyruvate (Sigma Kit 735-10, Sigma
Chemical Co. St. Louis, MO).

The remaining supernatant was

frozen for analysis of VFA (Quigley et al., 1991).

Statistical Analysis

Data were analyzed in a split plot design using
General Linear Mixed Models (GLMM) software (Blouin and
Saxton, 1990).

Time and time x treatment interactions were

used in the model to determine increases in metabolite
concentrations over time.

RESULTS

Acetoacetate concentrauions increased (P < .05) from

time 0 to 103 nM/lO^ cells in epithelial cells in animals
supplemented with lasalocid, while ACAC cells from control
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animals increased to 66 nM/lO^ cells (Figure 1). A
significant increase at 120 min over time 0 was observed in
both treatments; however, treatment concentrations were not
different from controls.

Significant production of BOHB (P < .01) above time 0
occurred at 120 min of incubation for cells from wethers

fed control and lasalocid diets (Figure 2).

Production of

BOHB by rumen epithelial cells increased in all incubations

with time.

The only exception was the 60 min time for

controls.

L(+)lactate production by rumen epthelial cells
increased from time 0 through 120 min (Figure 3).
Concentrations of L(+)lactate at 120 min were not different

between treatments.

However in both treatments 120 min

concentrations were higher (P < .05) than time 0.

Pyruvate production by rumen eptithelial cells

increased with time (P < .05) (Figure 4).

However, no

significant differences between treatments were detected at
any time.

L(+)lactate:pyruvate ratios were increased at 120 min
(Figure 5). There were no observed differences in the ratio
of lactate:pyruvate between treatments.

Acetoacetate:BOHB ratio remained relatively constant

with time (Figure 6),

except at 120 min in cells from

whethers on control diets.

Although at 90 and 120 min of
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incubation lasalocid treated animals tended to have a

higher ratio of ACAC:BOHB treatments were not significantly
different from each other.

DISCUSSION

Bergen and Bates (1984) reported that ionophores may

affect host cells, possibly altering metabolism of rumen,
hepatic and peripheral tissues.

Intravenous administration

of ionophores resulted in alterations of circulating
glucose (Armstrong and Spears, 1988) and steers fed

ionophores prior to slaughter had increased hepatic
gluconeogenic potential (Benz et al., 1989).

Benz et al.

(1989) concluded that ionophores may act directly on
metabolism of extraruminal tissues.

Trials 1 and 2

indicated a decrease in PDV production of ketone
bodies with lasalocid feeding.

Trial 2 indicated decreased

release of ketones by PDV.
Epithelial cultures from wethers on a forage based
diet with or without lasalocid resulted in no change in
either acetoacetate (ACAC) or BOHB concentrations or
ACAC:BOHB ratios after 120 min of incubation.

Due to the

insolubility of the ionophore it was not possible to add
lasalocid directly to the incubations, therefore, animals
were used as experimental units resulting in low degrees of

freedom.

It was shown by Bush et al. (1970) using rumen

epithelial slices and Baldwin and Jesse (1993) using
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isolated rumen epithelial cells that a shift in the ratio

of ACAC:BOHB occurs.

As propionate concentration was

increased in culture, the ketone body ratio shifted toward
more BOHB (Baldwin and Jesse, 1993).

Emmanuel (1981)

stated that the final step of propionate metabolism,
pyruvate to lactate, is energetically inefficient to the

cell, but it may be an important step for the regulation of
ketogenesis.

Baldwin and Jesse (1993) found that the final

step of ketogenesis, reduction of ACAC to BOHB, may be

stimulated by the production of NADH by propionate
metabolism.

BOHB.

This would result in the shift in ACAC to

The presence of intramitochondrial

phosphoenolpyruvate carboxykinase (PEPCK) may influence the
ratio of ACAC to BOHB.

Tilghman et al. (1975) reported

PEPCK to be almost exclusively mitochondrial in the avian

liver, but in human liver PEPCK was found in approximately
equal quantities in mitochondria and cytosol.

No data has

been reported specifying the location of PEPCK in rumen
epithelium.

If PEPCK is mitochondrial in rumen epithelium,

then the catalysis of malate to phosphoenolpyruvate (PEP)
would occur.

This would increase metabolism of propionate,

thereby increasing concentrations of intramitochondrial
malate with subsequent conversion of malate to PEP.

This

reaction releases NADH necessary for the conversion of
acetoacetate to BOHB, possibly responsible for the observed
shift in the ratios of these metabolites.
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Results in vivo by Heitmann and Fernandez (1986) and

Harmon et al. (1988; 1993) and Trials 1 and 2 of this study

have shown greater concentrations of HOHB than ACAC being
released by PDV.

Studies in vitro have shown the opposite

to occur (Bush et al., 1979; Baldwin and Jesse, 1993).

Results of the present study (Figure 6) are in agreement

with these findings, showing the ratio to be approxim.ately
4:1, ACAC:BOHB.

No changes in metabolism of propionate were indicated

by the measured end products.

Lactate concentrations,

while increased at 120 min, were similar between
treatments.

Ratios of ACAC:BOHB and concentrations of the

ketone bodies also were unchanged with treatment.

These

data indicate rumen epithelial metabolism was not altered
by pre-feeding of lasalocid.

Rates of BOMB production, probably from butyrate, are
consistent with previous reports by Baldwin and Jesse
(1991; 1993) and suggest that cell viability was maintained
throughout the 120 min incubation period.

The only notable

exception occurred at 60 min time for cells from animals in

control treatment.

It is possible that this low value

could have been due to a large number of dead or dying
cells.

However, this appears unlikely because lactate

production by cells from control wethers was comparable
with corresponding cells from lasalocid treated animals.
Similar concentrations of total ketones and ratio of
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ACAC:BOHB between treatments indicate similar metabolic

function of cells.

Therefore, it may be assumed that

lasalocid had no direct effect on ketogenic potential of

cells or a significant alteration of mitochondrial redox
state.

L(+)lactate production by rumen epithelial cells were
comparable to previous studies by Baldwin and Jesse (1993).
Lactate production increased with time verifying the
viability of cells through continued metabolism of
propionate.

No previous reports are available on

production of pyruvate by rumen epithelial cells.
Lactate:pyruvate ratios increased over time (Figure 5)
indicating a larger conversion of pyruvate to lactate and a
possible shift in cytosolic NAD:NADH ratio.

However, no

differences were obseirved in lactate:pyruvate between
treatments possibly indicating that no direct effect of
lasalocid on rumen epithelial cells occurred.

Experiments conducted in vivo, in which rumen
propionate was increased by ionophore addition, have shown
increased release of lactate into portal blood (Harmon et
al., 1988).

Harmon et al. (1988; 1993) reported decreased

uptake of glucose by PDV as observed in Trial 2.

Increased

release of lactate and a decrease in glucose uptake
indicate rumen epithelium may be an indication that rumen

epithelium is preferentially using propionate for energy in
lieu of glucose extraction from portal blood (Harmon et
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al., 1988).

Rumen epithelial tissue has been shown to

increase propionate metabolism to lactate, in vitro, as
concentrations of propionate were increased (Baldwin and
Jesse, 1993).
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VI

CONCLUSION

The objectives of this project were to investigate
possible changes in extraruminal and rumen epithelial cell
energy metabolism in wethers fed diets differing in

forage:concentrate ratio and with or without supplemental
lasalocid.

Trial 1 was designed to evaluate extraruminal energy
metabolism in wethers fed a forage based diet with or
without supplemental lasalocid.

Results indicate increased

hepatic glucose production in lasalocid supplemented
wethers even though uptake of measured gluconeogenic
precursors remained similar to control values.

More

notably, ionophore addition decreased splanchnic production
of ketone bodies.

Decreased hepatic production of BOMB was

primarily due to decreased liver uptake of NEFA.
Concentrate based diets with or without added

lasalocid was evaluated in trial 2.

Lasalocid

supplementation decreased BOHB production by PDV while

hepatic ketogenesis remained similar to control values.

Glucose release by PDV was increased with added lasalocid.
Further, lasalocid supplementation had no effect on

propionate release.

It has been documented previously that

ionophore supplementation increases proportions of

propionate in the rumen.

These previous findings would
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indicate a possible preferential use of propionate for
energy in lieu of extraction of glucose from portal blood.
Trial 3 was conducted with the objective of
determining if lasalocid supplementation had an effect on
rumen epithelial metabolism of VFA.

No differences were

detected in production of BOHB, ACAC, L(+)lactate or
pyruvate.

Ratios of ACAC:BOHB were calculated to determine

mitochondrial NAD:NADH ratios, and L-lactate:pyruvate
ratios calculated to represent cytosolic NAD:NADH ratios.
Lasalocid had no effect on either ratio calculated.

Ratios

of ACAC:BOHB observed in this trial were from approximately

2 to 3:1.

This ratio is opposite of those seen in PDV

release of ACAC and BOHB in trials 1 and 2.

In vivo data

indicated that release of BOHB exceeded ACAC by 4 fold.
Results obtained in trials 1 an 2 indicate a reduction

of ketogenesis in wethers supplemented with lasalocid,
however, this reduction occurred in different tissue beds.

Glucose metabolism was also affected by lasalocid addition
in trials 1 and 2.

As was the case in ketone body

metabolism, glucose metabolism was altered in different
tissue beds as a result of differing concentrate:forage
ratios.

Trial 3 showed no difference in VFA metabolism

between controls and lasalocid treated wethers.

One could

conclude that changes in metabolism of rumen epithelium and
possibly other tissues are a result of changes in rumen
metabolite concentration and subsequent release into the
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bloodstream and not a direct affect of lasalocid on host
cell metabolism.

Additional research is needed to determine the pathway

by which increased glucose is produced by PDV and hepatic
tissues in wethers supplemented with lasalocid.

Another

area of future investigation is the mechanism by which

lasalocid functions as an antiketogenic agent in forage and
concentrate based diets and how these differ.
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PARA-AMINOHIPPURIC ACID ANALYSIS

Reagents for Filtrate

1)

Double Distilled (DD) H2O

2) 20% Tricloroacetic Acid (TCA) (CCL3COOH)
(Sigma Chemical Co., cat. # T-6399)

Method for Filtrate

1)

Pipette 1.0 ml of blood or standard into 15 ml

2)

Pipette 5.0 ml of blood or standard mixture into

3)

Let stand 60 min or overnight (can be left at this

centrifuge tube containing 5.0 ml DD H2O.

second 15 ml centrifuge tube containing 5.0 ml 20% TCA.
stage if refrigerated.

4)

Filter through Whatman #4 filter paper into 16 x 150

mm glass culture tubes.

5)

Add boiling chip to each culture tube and place a

marble on top of each tube.
6)

Boil over low heat in water bath for 30 min after fine

bubbles appear in each tube.

7)

Cool at room temperature and remove marbles when cool.

8)

Standards from 1.5% PAH infusion solution are made

along with this using same method as for blood filtrate.

Make up a 1:500 dilution for sheep from 1.5% infusion
solution; 1:100 for dog from 0.25% infusion solution
(considered 10:10).

Be sure to run this dilution through the filtrate
procedure (do not have to boil).

Blank mixed with half DD H2O and half TCA (20%).
Reagents for Analvsis

1)

1.2 N Hydrochloric Acid (HCl)
(Fisher Scientific Co., cat. # A-144-S)

(1:10 dilution of 12.4 N HCl close enough)

2)

99

Sodium Nitrite {NaN02)
(Sigma Chemical Co., cat. # S-2252)

100 mg NaN02

3)

> 100 ml H2O

Ammonium Sulfamate (NH4OSO2NH2)
(Sigma Chemical Co., cat. # A-8670)

500 mg Ammonium Sulfamate
4)

> 100 ml H2O

Coupling Reagent N(-1-Naphthyl)Ethylenediamine
(Sigma Chemical Co., cat. # N-5889)

500 mg coupling reagent

> 100 ml H2O

All reagents should be refrigerated in brown bottles
and can be stored indefinately.
Analysis

1)

Pipette 1.0 ml of filtrate, standard or blank
test tube (in duplicate).

into

2)

Add 0.2 ml of 1.2 N HCl to all tubes and vortex.

The following steps should be done with no more
than 5 min between additions and tubes should be
vortexed after each addition.

Start time clock and add to all tubes:
0.1 ml sodium nitrite
0.1 ml ammonium sulfamate

0.1 ml coupling reagent
3)

Wait 10 min (minimum) for color development.

4)

Read absorbance on spectrophotometer at 540 nm.

5)

Calculations are made as a percentage of 100 standard.

PAH Stock Solution

1)

Para-Aminohippuric Acid (PAH)
(Eastman Kodak Corp., cat. # 5704)

2)

Sodium Hydroxide (NaOH)
(Fisher Scientific Co., cat # S-318)

100

Dissolve each reagent separately in Physiological
Sterile Saline (PSS):

44.8 g PAH
10.5 g NaOH

Then add NaOH solution to PAH solution and stir. May
have to heat gently to fully dissolve. Filter through
Whatman #4 filter paper. Titrate filtrate to pH 7.4 with 1
N HCl or 4 M NaOH. Bring final volume to 500 ml. Yields a
1.5% solution of sodium salt.
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GLUCOSE ANALYSIS

Sigma Chemical Co. #510 enzymatic colorimetric in
vitro determination for whole blood, plasma or serum is
based upon the following coupled enzymatic reactions:
glucose oxidase

Glucose 2H2O + O2

> Gluconic acid + 2H2O2

peroxidase

H2O2 + o-Dianisidine

> oxidized o-Dianisidine

(colorless)

(brown color)

The intensity of the brown color is measured at 450 nm

and is proportional to the original glucose concentration.
Reagents

1)

PGO Enzyme, Stock #510-6 (Preweighed capsules).
Contains glucose oxidase, peroxidase and buffer
salts.

One capsule is diluted with DD H20 to 100 ml and
stored in an amber bottle at 0 to 5° C.

2)

o-Dianisidine Dihydrochloride, Stock #510-50.

Preweighed vial is diluted with DD H2O to 20 ml
and stored at 0 to 5° C.

1.6 ml of this is added to 100 ml of PGO enzyme
solution.

3)

Glucose Standard solution. Stock #535-100/
Consists of a solution of beta-D-glucose, 100

mg/dl in benzoic acid, 0.1% and stored at 0 to 5°

C.

4)

0.3 N Barium Hydroxide Solution, Stock #14-3.

5)

5.0% Zinc Sulfate Solution, Stock #14-4, ZnSO^ * 7
H2O.
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Sample Collection and Preparation

Blood samples should be collected in a container with

a suitable anticoagulant. Immediately after sample is
collected, pipette 0.2 ml blood into test tube containing

1.8 ml DD H2O then vortex.

To each tube add 1.0 ml baium

hydroxide, vortex, then add 1.0 ml zinc sulfate and vortex

again.

Blank and standard are prepared in a similar manner

except 0.2 ml of DD H2O and 0.2 ml of glucose standard are
used, respectively, in place of the blood.

Tubes are then

centrifuged at 3 x g for 15 min at 0 to 5° C.
Analvsis

Prepare unknown, blank and standard tubes in duplicate
as follows:

1)

To each tube add 0.25 ml of supernatant from the
respective centrifuged unknown, blank and
standard tubes.

2)

Add 2.5 ml of PGO/color solution and vortex.

3)

Incubate all tubes at 37° C for 30 min in water
bath.

Avoid direct exposure to sunlight or bright
light.

4)

Following incubation, remove all tubes from
waterbath.

5)

Read absorbance at 450 nm.

Readings should be done within 30 min.
Calculation

Absorbance Unknown

Blood glucose (mg/dl)

X 100
Absorbance Standard
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APPENDIX C
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FREE FATTY ACID ANALYSIS

NEFA kit from WAKO and is based upon the following
reactions:

FFA are activated to CoA ester by aceyl CoA synthetase
ACS) .
ACS

R-COOH + ATP + CoA

> Acyl-CoA + AMP + PPi

Acyl-CoA is oxidized by acyl CoA oxidase (ACOD) to
produce hydrogen peroxide.

Acyl-CoA + O2

ACOD

> 2,3 trans-Enoyl-CoA + H2O2

Hydrogen Peroxide is acted on by peroxidase (POD) in
the presence of 3-methyl-N-ethyl-N-Beta-hydroxyethylaniline (MEHA) and 4-aminoantipyrine (AAP) to form a
product with a purple color which is measured
colorimetrically at 550 nm.

2H2O2 + MEHA + AAP

> Purple Quinone Product + 4H2O

Reagents

1)

Color reagent "A" Each vial contains:
Acyl-CoA synthetase
Ascorbate oxidase
CoA
ATP

4 Aminoantipyrine

2)

Diluent for color reagent "A" Bottle contains:
0.05 M Phosphate Buffer, pH 6.9
Magnesium Sulfate
Surfactant

Stabilizers

3)

Color reagent "B" Each vial contains:
Acyl-CoA oxidase
Peroxidase
MEHA

4)

Diluent for color reagent "B" Bottle contains:
Phenoxyethanol
Surfactant
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5)

NEFA Standard.

Each vial contains aqueous

solution with:
1.0 mM Oleic acid
Surfactant

Stabilizers
Procedure

1)

Preparation of standards:

Dilute the standard provided (1000 /xeq/l) with DD

H2O to provide 125, 250 and 500 fieq/1 standards.
Validation tests show DD H2O is an acceptable
diluent.

2)

Preparation of reagents:
Mix color regent "A" by adding 10 ml of the
specific "A" diluent to each vial. Gently invert
the vial until contents are completely dissolved

and then combine with 13.3 ml of DD H2O.

Mix color regent "B" by adding 20 ml of the
specific "B" diluent per vial. Gently invert
until contents are dissolved and then comine with

33.3 ml DD H2O.

Solutions should be stored between 2 to 8° C and
are stable for 5 d.

Do not freeze solutions or

expose them to direct sunlight.
Analvsis

1)

Assay each sample and standard in duplicate.

2)

Add 0.4 ml DD H2O to each tube.

3)

Add 0.1 ml of serum, plasma or standard to each
tube, followed by 0.35 ml of the combined reagent
"A" plus H20 mixture. Vortex and refrigerate for
up to 60 min if necessary (not required).

4)

Incubate tubes in a waterbath at 37° C for exactly
20 min.

5)

Following incubation, add 0.8 ml of the combined

reagent "B" plus H2O mixture to each tube, vortex
and incubate a second time at 37° C for exactly
20 min.
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tubes from
waterbath, allow to equilibrate
at room temperature for 5 min. then read at 550 nm
using blank prepared with reagents as zero.

6)

Remove

(Volume in ml)
Tube

Standard

Plasma

Blank

Reagent "A"
0.35

Reagent "B"
0.80

Std in

ixeq/l
125

0.025

If

II

250

It

If

II

500

II

11

11

1000

II

II

II

0.10

UNK

0.35

0.80

Comments

1)

Do not mix reagents and supplies from test kits
bearing different lot numbers.

2)

The assay is sensitive to heparin use as an
anticoagulent.

3)

Samples which are hemolyzed may yield inaccurate
results.

4)

Ascorbic acid interferes with assay; therefore,
ascorbate oxidase is included in regent "A"
mixture in kit.
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ACETOACETATE ANALYSIS

The acecoacetate analysis is a spectrophotometric
determination based upon a compound's (nicotinamide adenine
dinucleotide, NAD, in this analysis) unique property to
absorb a specific quantity of light of specific wavelength.
Acetoacetate is indirectly determined from the
concentration of NAD following the chemical reaction:

HOOC-CH2-CO-CH3 + NADH + H+ --> HOOC-CH2-CHOH-CH3 + NAD+
acetoacetate

beta-hydroxybutyrate

Acetoacetate is reduced, in a 1:1 stoichiometry, using
reduced nicotinamide adenine dinucleotide (NADH) in the

presence of the enzyme beta-hydroxybutyrate dehydrogenase
resulting in the formation of beta-hydroxybutyrate and
oxidized nicotinamide dinucleotide results in the
calculation of acetoacetate.
Treatment of 3lood

1)

Mix equal volumes of whole blood and 1 M HClO^

immediately after sampling.

2)

Centrifuge at 3 x g for approximately 15 min.

3)

Neutralize excess HCIO^ with KOH so that the final

4)

Centrifuge off the potassium perchlorate formed at
approximately 3 x g for 15 min and then pipette
from the supernatant.

5)

Samples must be analyzed within 24 h of

pH is between 6.0 and 8.0.

collection.
Reagents

1)

0.1 M Poshphate Buffer (pH 6.8)

1.36 g KH2PO4

>

100 ml ddH20

1.74 g K2HPO4

>

100 ml ddH20

Mix equal volumes of each solution.
one or the other to balance pH.
2)

Chech pH and add

NADH (approx. 1 mM) (Disodium Salt) (Grade II, 98%
Pure) (Boehringer Mannheim, cat. # 128023)
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0.010 g NADH

>

6.0 ml ddH20

Make up on day of use.

3)

3-Hydroxybutyrate Dehydrogenase (5.0 mg/ml)
(Grade II) (Boehringer Mannheim, cat. # 127841)

4)

1.5 mM Acetoacetic Acid (ACAC) (Lithium Salt)

(90 to 95% pure) (Sigma Chemical Co., cat # A8509)

0.01620 g CH3COCH2COOH

--->

100 ml ddH20

Standards

Dilute to the follwing concentrations for the working
statndards: 0.15, 0.09, 0.075, 0.045, and 0.0225 mM.
Use two zero concentration standards as blanks.

The standards must be taken through the entire
procedure, as small amounts of perchlorate will affect
the affect enzyme activity.

Pipette into conical centrifuge tubes:

1.0 ml standard and 1.0 ml of 1 M HCIO^
Neutralize to pH 6.0 to 8.0. (Remember to record the
volume of buffer added to adjust pH!!!)
Centrifuge at 3 x g for 15 min.
Standard dilutions:

A)

0.15 = 2.0 ml of 1.5 mM ACAC plus 18.0 ml ddH20

B)

0.09 = 12.0 ml of A plus 8.0 ml ddH20

C)

0.075 = 4.0 ml of A plus 4.0 ml ddH20

D)

0.045 = 10.0 ml of B plus 10.0 ml ddH20

E)

0.025 = 10.0 ml of D plus 10.0 ml ddH20

Analysis

Pipette into 12 x 75 mm culture tubes:
0.5 ml buffer

Sample - 1.00 ml
Standard - 1.00 ml
0.05 ml NADH

Ill

Read El at 340 nm.

Add 0.005 ml 3-Hydroxybutyrate Dehydrcgenase, vortex,
and incubate at room temperature for approximately 22
min.

Read E2 at 340 nm,
IMPORTANT

NADH will "react" slowly at room temperature but about
the same rate in all samples. The zero concentration
ACAC standards can be used as a control for this.

Pipette NADH into all of the cuvettes at known time
intervals, i.e., 15 to 60 seconds. Then read El in
all cuvettes at the same timed intervals.
and read E2 at same timed intervals.

Incubate

Calculations

Calculate El minus E2 for all standards, samples and
blanks:

Change in E of standard minus change in E of blank.
Change in E of sample minus change in E of blank.
Plot a standard curve of change in E of standard
versus concentration.

Read the concentration of the samples from the curve.
Multiply by appropriate dilution factors.

112

APPENDIX E

113

BETA-HYDROXYBUTYRATE ANALYSIS

The beta-hydroxybutyrate analysis is a
spectrophotometric determination based upon a compound's

(nicotinamide adenine dinucleotide, NAD, in this analysis)
unique property to absorb a specific quantity of light of
specific wavelength. Beta-hydroxybutyrate is indirectly
determined from the concentration of NAD following the

chemical reaction:

HOOC-CH5-CHOH-CH3 + NAD+

> COOH-CH2-CO-CH3 + NADH + H+

beta-hydroxybutyrate

acetoacetate

Beta-hydroxybutyrate is oxidized, in a 1:1
stoichiometry, using oxidized nicotinamide adenine
dinucleotide (NAD+) in the presence of the enzyme betahydroxybutyrate dehydrogenase, resulting in the formation
of acetoacetate and reduced nicotinamide dinucleotide

(NADH).

The change in absorption between the reduced and

the oxidized forms of nicotinamide adenine dinucleotide

results in the calculation of beta-hydroxybutyrate.
Treatment of Blood

1)

Mix equal volumes of whole blood and IM HClO^

2)

Centrifuge at 3 x g for approximately 15 min.

3)

Neutralize excess HC10,j with KOH so that the final

4)

Centriguge off the potassium perchlorate formed at
approximately 3 x g for 15 min and then pipette
from the supernatant.

5)

Samples must be analyzed within 24 h of

immediately after sampling.

pH is between 6.0 and 8.0.

collection.
Reagents

1)

0.1 M Tris-HCl Buffer (pH 8.5)

2.42 g Tris

>

50 ml ddH20

pH = 8.5 with 1 M HCl
Final volume = 200 ml
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2)

Hydrazine-Tris Buffer (Burnt Bacon Buffer)
2.5 ml Hydrazine Hydrate (Extremely toxic)
0.05 g EDTA
12.5 ml 1 M HCl
Volume

> 50 ml with Tris-HCl Brffer

Check pH, should be 8.5
Make up on day of use.

3)

14 mM NAD+ (Free Acid) (Grade II, 98% pure)
(Boehringer Mannheim, cat. # 127990)

0.06 g NAD+ ---> 3.0 ml ddH20
4)

3-hydroxybutyrate dehydrogenase (5.0 mg/ml)
(Grade II) (Boehringer Mannheim, cat # 127841)

5)

2.0 mM 3-Hydroxybutyric Acid (Sodium Salt)
(98% pure) (Sigma Chemical Co., cat. # H-6501)

0.0656 g CH3CHOHCH2COOH ---> 250 ml ddH20
Standards

Dilute to the following concentrations for the working
standards: 2.0, 1.6, 1.2, 0.8 and 0.4 mM.
Use two zero concentration standards as blanks.

The standards must be taken trough the entire
procedure as small amounts of perchlorate will affect
enzyme activity. Pipette into conical centrifuge
tubes:

1.0 ml standard and 1.0 ml of 1 M HClO,^.
Neutralize to pH 6.0 to 8.0.

(Remember to record the

volume of buffer added to adjust pH !!!).
Centrifuge at 3 x g for 15 min.
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Standard dilutions:

A)

2.0 = 20.0 ml of 2.0 mM BOHB plus 0.0 ml

B)

1.6 = 16.0 ml of 2.0 mM BOHB plus 4.0 ml

C)

1.2 = 12.0 ml of 2.0 mM BOHB plus 8.0 ml

D)

0.8 =

8.0 ml of 2.0 mM BOHB plus 12.0 ml

E)

0.4 =

4.0 ml of 2.0 mM BOHB plus 16.0 ml

ddH20
ddH20

ddH20

ddH20
ddH20

Analysis

Pipette into 12 x 75 mm culture tubes:
0.5 ml buffer

Sample - 0.25 ml plus 0.75 ml ddH20
Standard - 0.25 ml plus 0.75 ml dto20
0.05 ml NAD+
Read El at 340 nm.

Add 0.005 ml 3-hydroxybutyrate dehydrogenase, vortex,
and incubate at room temperature for approximately 45
min.
Read E2 at 340 nm.
IMPORTANT

NAD+ and hydrazine form a complex which absorbs at 340
nm. Therefore, a slow constant increase in absorbance
occurs. This is similar to the acetoacetate assay but

in reverse. So pipette the NAD+ and enzyme and take
the absorbance readings at timed intervals as
described for the acetoacetate assay.
Calculations

Same as for acetoacetate, except change in E is
calculated from E2 minus El.
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VOLATILE FATTY ACID ANALYSIS

Volatile fatty acid concentrations were determined in
plasma based on the method of Reynolds et al. (1986), with
modifications by Quigley et al. (1991) . Procedure,
including modifications is described below.
Reagents

H20)

A)

H20/Triton-X mixture (20 /il Triton-XlOQ/250 ml

B)

1 M Sodium Hydroxide (NaOH)

C)

10 mM Sodium Hydroxide (NaOH)

D)

IN Hydorchloric acid (HCl)

E)

0.3 N Zinc Sulfate (ZnSO^)

F)

0.3 N Barium Hydroxide (BaOH)

G)

Internal Standard (1.31 mM 2-ethylbutyric acid)

H)

0.01 M Oxalic acid

Note: The concentrations of zinc sulfate and barium

hydroxide must completely neutralize each other.
Column Preparation

I)

Packing:

a)

Anion Colums are prepared using BIO-REX 5

resin (100-200 Mesh, Bio-Rad Cat. # 140-7841)

b) Cation colums are prepared using AG SOW-8
resin (100-200 Mesh, Bio-Rad Cat. # 142-1441)

Resins are first prepared by making a slurry of each
and pouring off fines. Stir resins twice with transfer
pipette and allow to settle, removing fines each time.
Stir each slurry once again and transfer resins into
columns.

(Poly-Prep Columns, Bio-Rad Cat. # 731-1550)
Each column receives:

a)
b)

Cation column receives 1.8 ml resin
Anion column receives 0.6 ml resin
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2)

Regeneration;
a)

Cation
1)

Fill twice with IM NaOH and stir resin

2)

Rinse twice with dd H2O

3)

Fill columns with IN HCl twice stirring
each time

4)
b)

Rinse twice with dd H2O

Anion

1)

Fill columns twice with IM NaOH stirring
each time

2)

Rinse twice with dd H2O

Notes;

1)
Columns must be stored generated and resin must
not be allowed to dry out!!!

2)

Stirring columns more oftern will minimize the

risk of establishment of channels through resin.
Assay

1)

Regenerate columns, as above, and fill with H2O

2)

In 50 ml centrifuge tubes add:

6 ml H20/Triton-X mixture
2 ml plasma; vortex; let stand 5 min
4 ml BaOH; vortex; let stand 5 min

4 ml ZnSO^; vortex; let stand 5 min
3)

Centrifuge for 15 min at 13,000 rpm (15,000 x g)

4)

Pour supernatant into 50 ml tube

5)

Add 0.2 ml internal standard

6)

Allow H2O to drain from columns, then place cation
columns over anion columns.
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7)

Pour supernatant/internal standard mixture onto
the cation columns. Allow to drip through both
columns completely.

8)

Rinse tube 2 x with 2 ml dd H2O and pour through
columns, allowing each rinse to drip through
completely.

9)

Rinse top column once with 2 ml H2O, allow to drip
through both columns.

10) Remove top columns and fill columns with H2O.

11) Rinse bottom column once with 2 ml H2O, allow to
drip through.

12) Place a vial beneath each bottom column; add 10 ml

of 10 mM NaOH and allow to drip through

completely; pH of collected liquid should be
above 11, check at least one in each rack.
13) Place vials in covection oven until dry.

(Temperature should not exceed 50° C)

14) Reconstitute dry sample with 1 ml 0.01 M oxalic
acid

15) Allow sample to stand for one hour

16) Solution is filtered using a 0,45 /xm syringe
filter

(Aerodisc No. 4184, Gelman Science) and

transferred to a gas chromatograph vial and
capped.

17) Samples were analyzed for volatile fatty acids by
gas chromatography (30 m x 0.53 mm x 1.0 /im

capillary column coated with stabilwax-DA, flame
ionization detector, helium carrier at 6 ml/min.)
using a Hewlett Packard model 5890 gas
chromatograph.

18) Sample acid concentrations were corrected for
recovery of internal standard.
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L-LACTATE

Principle of the test. The method is based on the
enzymatic conversion of lactate to pyruvate by lactate
dehydrogenase with the consumption of NAD:
Lactate + NAD+

> Pyruvate + NADH + H+
LDH

The reaction normally goes toward pyruvate; therefore,
hydrazine is included in the reaction to trap pyruvate, and
force the reaction toward complete consumption of lactate.
The procedure is based on the Sigma kit 826-uv,
Lactate, and Gutmann, I., and A.W. Wahfield.

1974. Methods

of Enzymatic Analysis. H. V. Gergmeyer, ed. Academic Press,
NY.

pp 1464-1491.

Reagents

1)

Lactate Dehydrogenase (LDH) (Sigma Chemical Co.,
cat. # 826-6)

2)

Glycine buffer (Sigma Chemical Co., cat # 826-3)
Contains glycine (0.6 mol/1), and hydrazine (0.5
mol/1). pH is 9.2

Glycine buffer may be made in the lab by weighing
23 g glycine and 20 ml hydrazine hydrate (54%
hydrazine, same as ketone procedures) and making

up to 500 ml with dd H2O.

should be approximately 9.

The pH of the solution

3)

NAD (Same as in ketone procedures)

4)

Lactic acid (Sigma Chemical Co., cat # 826-10)
Contains L-lactate (4.44 mmol/1), with sodium
azide as a preservative.

5)

Perchloric acid (8% w/v). Not supplied by kit.

Prepare by adding 140 ml of 70% perchloic acid to

a 2 1 volumetric.

Add dd H2O to volume.

Sample Collection

1)

Following blood collection, quickly pipette 2.0 ml
blood into a 15 ml centrifuge tube containing 4.0

ml 8% perchloric acid.

Mix by inversion and

vortex. Place the mixture in the refrigerator
until centrifugation.
2)

Centrifuge mixture for 15 min at 1,500 x g.
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3)

Analysis is run on supernatant. If stored,
supernatant should be frozen and analysis should
be done within 14 d of collection.

Analysis

1)

Standards:

A series of standard dilutions should be made up

using dd H2O as a zero and the standard descibed

above as a 100.
samples.
2)

These should be treated just as

Prepare solution by adding to 10 mg NAD, 2.0 ml

glycine and 4.0 ml dd H2O.
Note:

This is enough to do 30 samples.

3)

Pipette 200 fil of NAD/glycine solution into each
well of a 96 well microtiter plate. Add 20 fil of
sample or standard.

4)

Read absorbance using KinetiCalc software at 340
nm. (El)

5)

Add 5 ul of LDH to each well. Incubate for 15 min
at 37° C.

6)

Read absorbance using KinetiCalc software at 340
nm. (E2)

7)

Regress absorbance of standards against
concentration of the respective standard and
calculate unknowns using standard curve.

123

APPENDIX H

124
PYRUVATE PROCEDURE

This procedure uses the same principles as the lactate
procedure by the measurement of NADH. This procedure was
received from Ransom L. Baldwin VI, a research scientist
with USDA Beltsville, Maryland.
Reagents
1)

Trizma base (1.5 M, MW 121.1)

To make stock buffer (1.5 M) 18.18 g Trizma base

to 100 ml dd H2O.
2)

Working buffer
3 ml dd H20

22 ml Trizma base (stock buffer)

.0128 g NADH

3)

Pyruvic acid (Sigma Chemical Co., cat. # P-2256)

Sample Collection

1)

Following blood collection, quickly pipette 2.0 ml
blood into a 15 ml centrifuge tube containing 4.0
ml 8% perchloric acid. Mix by inversion and
vortex. Place the mixture in the refrigerator
until centrifugation.

2)

Centrifuge mixture for 15 min at 1,500 x g.

3)

Analysis is run on supernatant.

If stored,

supernatant should be frozen and analysis should
be done within 14 d of collection.

Analysis

1)

Standards:

A series of standard dilutions should be made up

using dd H2O as a zero and the standard descibed

above as a 100.
samples.

2)

These should be treated just as

Add to 96 well microtiter plate 150 (jlI sample or
standard.

3)

Add to each well of 96 well microtiter plate 100
fil working buffer.

4)

Read absorbance using KinetiCalc software at 340
nm. (El)
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5)

ul of
c
Add 5 ul
LDH to each well. Incubate for 15 min

7^ C.

at 3

6)

Read absorbance using KinetiCalc software at 340
nm. (E2)

7)

Regress absorbance of standards against
concentration of the respective standard and
calculate unknowns using standard curve.
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